data_2bz2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bz2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.51 ' CG1' HG23 ' A' ' 79' ' ' THR . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.488 HG12 ' CG ' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.51 HG23 ' CG1' ' A' ' 65' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.455 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.549 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 93' ' ' LEU . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.455 ' CD2' HG11 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.438 ' CG1' HG23 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.446 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 44.6 t-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.404 ' SD ' HD13 ' A' ' 103' ' ' LEU . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.455 ' CD1' ' HE3' ' A' ' 69' ' ' MET . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.474 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.455 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 69' ' ' MET . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 41' ' ' THR . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 65' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.58 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.473 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 17.5 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD12 ' CA ' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 78' ' ' VAL . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.483 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.45 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.452 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' CG2' ' A' ' 44' ' ' VAL . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.482 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CA ' HD12 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 104' ' ' LYS . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' N ' HD22 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 93' ' ' LEU . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.474 ' ND2' ' HB1' ' A' ' 86' ' ' ALA . 60.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 79' ' ' THR . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 65' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HB1' ' ND2' ' A' ' 40' ' ' ASN . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.526 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 93' ' ' LEU . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.264 0.554 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' CD2' ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.555 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.518 HD12 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 65' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.465 ' CD2' HG11 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 107' ' ' ILE . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' CB ' ' A' ' 86' ' ' ALA . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 78' ' ' VAL . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' THR . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.446 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CG ' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 87' ' ' ASP . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.453 ' O ' HG21 ' A' ' 101' ' ' VAL . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.508 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.443 HD22 ' SD ' ' A' ' 49' ' ' MET . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 27.8 m120 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.469 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 44.5 t-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.41 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.51 HG21 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.518 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.516 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 58' ' ' PHE . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.524 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.494 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.565 ' CG2' ' CG2' ' A' ' 79' ' ' THR . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.444 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 44' ' ' VAL . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.565 ' CG2' ' CG2' ' A' ' 65' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.479 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.491 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 93' ' ' LEU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.447 ' CD1' ' HE1' ' A' ' 69' ' ' MET . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.447 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CG2' ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 28.1 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 101' ' ' VAL . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.52 ' CG1' HG23 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 65' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.52 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.427 HD22 HG11 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 ' CG1' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 17.0 m120 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB1' ' A' ' 86' ' ' ALA . 43.3 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 78' ' ' VAL . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' CE2' HD11 ' A' ' 93' ' ' LEU . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 79' ' ' THR . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.523 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 65' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.545 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.52 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.487 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.9 m120 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 107' ' ' ILE . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' OE2' HG21 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.455 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 65' ' ' ILE . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 77' ' ' PHE . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.466 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 69' ' ' MET . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 40' ' ' ASN . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 93' ' ' LEU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.46 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.526 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 23.7 m120 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.545 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 38.5 t30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.46 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' ND2' ' A' ' 40' ' ' ASN . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.51 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 42' ' ' LEU . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 86' ' ' ALA . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.42 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.447 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.496 ' CD2' HD12 ' A' ' 42' ' ' LEU . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.456 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.532 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.505 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.273 0.558 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.5 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' HD11 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 HD11 ' A' ' 67' ' ' LEU . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 65' ' ' ILE . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 58' ' ' PHE . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 26.6 m120 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.431 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 53.3 t30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 78' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CE2' HG12 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.545 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.4 HG22 HG21 ' A' ' 78' ' ' VAL . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.452 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.421 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' A' ' 58' ' ' PHE . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.5 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 23.3 m120 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.518 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.453 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.46 ' CG1' HG23 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.445 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.518 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.46 HG23 ' CG1' ' A' ' 65' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.528 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.457 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.458 HD22 HG11 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 107' ' ' ILE . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 23.6 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HE1' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' HE1' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.44 HD23 ' HG3' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.499 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 58' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' HG23 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD22 ' CG1' ' A' ' 105' ' ' VAL . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.446 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' THR . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.509 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 69' ' ' MET . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 69' ' ' MET . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.462 ' OH ' ' CB ' ' A' ' 58' ' ' PHE . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.509 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.512 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 90' ' ' VAL . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 48.2 t-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG12 HD23 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' OE2' HG21 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 103' ' ' LEU . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 53' ' ' LEU . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' A' ' 78' ' ' VAL . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 HG23 ' A' ' 79' ' ' THR . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.445 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.572 HG13 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 HG23 HG12 ' A' ' 65' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.526 HG21 ' CG1' ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.567 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.532 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.458 HD23 HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.16 147.38 60.14 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -123.89 149.71 45.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -57.88 -35.46 71.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.64 -153.85 41.11 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -165.89 92.12 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD22 ' CB ' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.427 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.526 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.51 ' CG1' HG23 ' A' ' 79' ' ' THR . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.415 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.488 HG12 ' CG ' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.51 HG23 ' CG1' ' A' ' 65' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.455 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.518 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.406 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 93' ' ' LEU . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.455 ' CD2' HG11 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.438 ' CG1' HG23 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.96 143.09 33.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -73.96 142.53 45.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.97 -39.6 86.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -73.34 138.78 78.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 113' ' ' MET . 50.1 Cg_endo -70.39 144.8 51.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.688 2.258 . . . . 0.0 111.78 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 112' ' ' PRO . 70.6 mtm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.8 -18.47 36.82 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.799 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.22 145.81 49.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.01 26.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.446 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 44.6 t-20 -161.32 90.83 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 109.46 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG12 ' CD2' ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.404 ' SD ' HD13 ' A' ' 103' ' ' LEU . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.455 ' CD1' ' HE3' ' A' ' 69' ' ' MET . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CE2' ' CD1' ' A' ' 93' ' ' LEU . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.474 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.455 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HB2' ' SD ' ' A' ' 69' ' ' MET . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 41' ' ' THR . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' CG2' HG12 ' A' ' 65' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.465 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.516 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.58 ' CD1' ' CE2' ' A' ' 58' ' ' PHE . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.41 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.43 ' CD2' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.446 ' O ' ' OD1' ' A' ' 106' ' ' ASN . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.97 61.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -61.77 147.31 46.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -56.86 -33.33 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.421 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 39.4 mt-30 -124.39 161.0 50.34 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -70.27 143.16 47.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.754 2.303 . . . . 0.0 111.816 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.45 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.59 -21.25 34.53 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.69 2.26 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -54.76 -36.54 64.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.13 150.63 28.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -172.34 -160.65 21.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.473 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 17.5 t-20 -179.95 97.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -1.113 . . . . 0.0 109.478 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD12 ' CA ' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.472 ' CG2' HG22 ' A' ' 78' ' ' VAL . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.483 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.64 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HB2' HG23 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.45 ' SD ' ' CD1' ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.452 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.43 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 HG22 ' CG2' ' A' ' 44' ' ' VAL . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.482 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CA ' HD12 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.64 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 104' ' ' LYS . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' N ' HD22 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' ' 93' ' ' LEU . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.61 121.85 28.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -58.66 -32.76 69.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 29.0 ttpt -73.61 134.13 43.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -122.42 89.15 49.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 144.24 54.32 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.711 2.274 . . . . 0.0 111.696 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.503 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -69.84 139.29 39.61 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.702 2.268 . . . . 0.0 111.79 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -129.33 143.0 50.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HD3' ' NZ ' ' A' ' 110' ' ' LYS . 25.7 mttt -58.44 -27.68 64.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.6 -152.28 31.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.474 ' ND2' ' HB1' ' A' ' 86' ' ' ALA . 60.5 t-20 -162.08 91.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 109.424 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.55 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.4 ' CG2' ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 HG23 ' A' ' 79' ' ' THR . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.454 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.44 HG23 HG12 ' A' ' 65' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.456 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.474 ' HB1' ' ND2' ' A' ' 40' ' ' ASN . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.526 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 93' ' ' LEU . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.456 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.92 144.76 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -115.97 147.65 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.89 . . . . 0.0 109.607 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.51 ' NZ ' ' HD3' ' A' ' 38' ' ' LYS . 90.1 mttt -91.33 142.88 27.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -127.95 89.63 49.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.38 142.68 45.79 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 111.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtm . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.524 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.06 -21.1 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.752 2.302 . . . . 0.0 111.858 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -57.9 -36.25 72.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -76.5 138.14 40.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.451 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.77 -168.88 35.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 -160.74 91.82 0.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -1.151 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD22 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG11 ' CD2' ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.434 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.555 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.518 HD12 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.483 HG23 ' CG1' ' A' ' 65' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.519 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.542 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.465 ' CD2' HG11 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 107' ' ' ILE . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.41 149.28 24.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -115.63 145.13 42.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.601 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -57.99 -37.55 74.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -84.37 128.81 60.34 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.528 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.01 145.21 55.0 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.484 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.08 -20.13 38.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.845 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.59 151.03 39.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -56.74 -32.7 65.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.388 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 -143.57 14.49 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -150.09 86.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -1.157 . . . . 0.0 109.41 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD12 ' CB ' ' A' ' 86' ' ' ALA . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 78' ' ' VAL . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' THR . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD11 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.427 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CG ' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 87' ' ' ASP . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.581 ' HG ' ' CE2' ' A' ' 61' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.453 ' O ' HG21 ' A' ' 101' ' ' VAL . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.508 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.443 HD22 ' SD ' ' A' ' 49' ' ' MET . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 27.8 m120 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.86 142.68 58.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 112' ' ' PRO . 47.5 mtt-85 -123.31 150.37 43.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -60.24 -36.57 78.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.434 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.9 79.66 73.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 109' ' ' ARG . 48.1 Cg_endo -69.2 -20.93 36.82 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.735 2.29 . . . . 0.0 111.804 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.61 146.72 62.02 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.672 2.248 . . . . 0.0 111.774 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -121.65 136.72 54.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.955 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.7 mttm -58.93 -35.68 73.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.552 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.84 -163.2 39.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.469 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 44.5 t-20 -173.14 97.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 ' OG1' ' HB3' ' A' ' 112' ' ' PRO . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.41 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.441 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.51 HG21 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.518 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' CYS . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.516 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.507 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.491 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.555 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 58' ' ' PHE . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' N ' ' HG2' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.524 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 120.89 15.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.53 -38.4 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.731 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -78.02 134.94 37.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 160.76 45.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HB3' ' OG1' ' A' ' 41' ' ' THR . 49.4 Cg_endo -69.31 -18.46 39.13 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.739 2.293 . . . . 0.0 111.85 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.16 142.17 49.77 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.736 2.291 . . . . 0.0 111.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.14 142.26 51.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -57.92 -25.51 60.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.18 141.16 45.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 -157.77 84.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.433 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.442 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 78' ' ' VAL . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.494 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.494 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.492 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.541 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.565 ' CG2' ' CG2' ' A' ' 79' ' ' THR . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.462 ' N ' HG22 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.444 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 44' ' ' VAL . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.565 ' CG2' ' CG2' ' A' ' 65' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.438 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.479 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.501 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.578 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.492 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.491 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.458 HG22 ' HA ' ' A' ' 93' ' ' LEU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.521 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.531 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.27 145.0 53.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -70.31 144.27 51.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -56.42 -34.62 66.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.674 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.15 102.84 54.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.549 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.5 -18.17 38.37 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.749 2.299 . . . . 0.0 111.774 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.503 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -70.24 -16.83 35.64 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.651 2.234 . . . . 0.0 111.695 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -56.7 -36.69 69.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.436 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -101.26 152.48 20.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.64 -168.68 39.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 -160.46 91.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.509 HD12 ' CB ' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.441 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.423 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.447 ' CD1' ' HE1' ' A' ' 69' ' ' MET . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.523 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.504 ' CG2' ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.447 ' HE1' ' CD1' ' A' ' 54' ' ' LEU . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 42' ' ' LEU . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.504 ' O ' ' CG2' ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.576 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.519 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.635 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 28.1 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.401 ' O ' HG21 ' A' ' 101' ' ' VAL . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.475 ' N ' HG13 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 HG21 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.65 69.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.6 mtm-85 -119.39 149.31 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.0 -35.36 73.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.76 156.62 86.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -18.73 36.65 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.661 2.241 . . . . 0.0 111.751 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.76 147.53 63.06 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.689 2.26 . . . . 0.0 111.776 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -119.14 149.48 41.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -90.7 140.44 29.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -79.47 -166.59 32.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 179.04 100.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.142 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.466 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.558 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.544 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.52 ' CG1' HG23 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 ' CG1' ' A' ' 65' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.52 ' O ' ' CG2' ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.427 HD22 HG11 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.5 HG13 ' CG1' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 17.0 m120 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.27 147.6 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -131.87 148.01 52.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 27.4 pttt -132.3 145.42 51.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.275 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.5 70.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HG3' ' A' ' 110' ' ' LYS . 49.9 Cg_endo -70.27 -20.79 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.631 2.221 . . . . 0.0 111.781 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -69.63 146.15 60.09 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -118.12 154.93 31.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.0 130.15 35.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.6 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.93 -167.38 41.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB1' ' A' ' 86' ' ' ALA . 43.3 t-20 -168.2 95.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.121 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 78' ' ' VAL . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.417 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' CE2' HD11 ' A' ' 93' ' ' LEU . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.465 HG12 HG23 ' A' ' 79' ' ' THR . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.441 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.523 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 65' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' CB ' HD23 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.545 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.52 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.463 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.487 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.9 m120 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 107' ' ' ILE . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.95 153.99 36.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -120.46 145.43 47.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -59.22 -40.65 86.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.24 82.19 65.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 109.491 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.52 145.18 57.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 111.775 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 109.508 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.12 150.28 65.82 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.666 2.244 . . . . 0.0 111.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -58.54 -32.06 68.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.38 146.62 24.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 172.77 37.22 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 -149.5 86.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' OE2' HG21 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.455 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.438 HD23 HG13 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.645 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE2' ' HG ' ' A' ' 93' ' ' LEU . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CG2' ' CG2' ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 65' ' ' ILE . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 77' ' ' PHE . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.466 ' HA ' ' HB1' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.43 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 69' ' ' MET . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.486 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' CG2' ' CG2' ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.404 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' CB ' ' OD1' ' A' ' 40' ' ' ASN . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.645 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 93' ' ' LEU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.46 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.526 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.526 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG13 ' HA ' ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.457 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 23.7 m120 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.1 147.24 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 57.5 44.91 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.353 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 19.8 tttm -56.09 -38.77 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 109.529 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.567 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 1.7 mt-30 172.03 -64.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -69.91 -19.27 35.61 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.711 2.274 . . . . 0.0 111.705 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.75 147.78 63.7 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.813 2.342 . . . . 0.0 111.824 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -115.23 146.37 41.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -58.92 -38.81 79.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.49 -174.8 50.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.545 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 38.5 t30 -161.8 92.66 0.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.444 HG23 ' CZ ' ' A' ' 58' ' ' PHE . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.46 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.403 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 66' ' ' ASP . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.545 ' CB ' ' ND2' ' A' ' 40' ' ' ASN . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.51 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.51 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.41 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.452 HD12 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -125.74 147.73 49.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -60.28 -37.93 82.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -87.39 119.63 70.89 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.437 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.73 147.49 63.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.694 2.263 . . . . 0.0 111.787 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.42 -16.69 39.15 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.772 2.314 . . . . 0.0 111.797 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -119.46 149.91 41.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' A' ' 41' ' ' THR . 40.9 mttp -62.75 -19.74 64.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.904 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.09 56.3 14.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 48.73 62.91 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 109.407 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 42' ' ' LEU . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 86' ' ' ALA . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.474 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.42 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.532 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.558 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 67' ' ' LEU . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.447 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 HD13 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.496 ' CD2' HD12 ' A' ' 42' ' ' LEU . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.456 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.532 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.47 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.505 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.456 ' CG1' HG21 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.77 147.38 50.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -129.75 148.96 51.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -56.6 -35.68 68.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 148.41 97.34 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.44 145.02 57.66 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.743 2.295 . . . . 0.0 111.786 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' ARG . 50.3 Cg_endo -69.93 143.94 51.57 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.652 2.234 . . . . 0.0 111.861 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' PRO . 63.2 mtt-85 44.51 -151.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -82.57 153.73 25.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.03 -166.0 30.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -162.9 91.88 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.5 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD13 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CE2' HD11 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 HD11 ' A' ' 67' ' ' LEU . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 65' ' ' ILE . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD11 HD11 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.465 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.509 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 91' ' ' ALA . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 87' ' ' ASP . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD11 ' CE2' ' A' ' 58' ' ' PHE . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.501 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 26.6 m120 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.9 70.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -117.11 144.7 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -124.05 132.06 53.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -61.38 150.62 79.66 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.497 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.94 -18.02 36.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.732 2.288 . . . . 0.0 111.763 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.17 148.36 62.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.246 . . . . 0.0 111.763 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -118.74 148.21 43.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -57.19 -35.11 69.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.25 -164.37 40.19 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.431 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 53.3 t30 -155.0 88.11 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB3' HG13 ' A' ' 78' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.509 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.471 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CE2' HG12 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.545 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.4 HG22 HG21 ' A' ' 78' ' ' VAL . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.452 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.503 ' N ' HD12 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.421 ' SD ' ' CA ' ' A' ' 51' ' ' PRO . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' A' ' 58' ' ' PHE . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' O ' HG22 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.495 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.527 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.5 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.509 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 23.3 m120 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.28 80.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -100.3 140.71 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.48 -36.45 84.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.07 114.06 2.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 146.1 56.46 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.724 2.282 . . . . 0.0 111.834 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.297 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 48.2 Cg_endo -69.38 -14.38 37.18 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.686 2.257 . . . . 0.0 111.742 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -58.75 -33.28 70.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -60.37 -40.26 90.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -158.52 34.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -159.38 91.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.518 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.453 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.491 ' O ' ' CD1' ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.627 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' CG2' ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.46 ' CG1' HG23 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.445 ' HE3' ' CD1' ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.518 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' CD1' ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 HG23 ' CG1' ' A' ' 65' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' CB ' HD22 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.553 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.627 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.528 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.457 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.457 ' HB ' ' CG2' ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.458 HD22 HG11 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 94' ' ' ASN . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 107' ' ' ILE . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.9 51.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -145.67 169.22 18.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.923 . . . . 0.0 109.568 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -56.26 -33.77 65.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.73 80.5 24.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.84 -16.34 41.35 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.703 2.269 . . . . 0.0 111.821 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.39 -22.43 33.78 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -58.32 -34.6 70.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -60.97 -28.91 69.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.52 -172.23 42.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 23.6 t-20 -157.93 90.97 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.478 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' O ' ' HE1' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' HE1' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.424 HD11 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CE2' HD13 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.578 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.44 HD23 ' HG3' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.499 ' CB ' ' HB3' ' A' ' 66' ' ' ASP . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.456 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.413 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.577 HD13 ' CE2' ' A' ' 58' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.515 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG1' HG23 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.84 149.75 29.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -120.26 141.52 49.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.67 146.14 50.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.363 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.38 160.62 49.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.514 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.65 145.64 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.743 2.295 . . . . 0.0 111.829 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' HB1' ' NH1' ' A' ' 37' ' ' ARG . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.15 143.45 53.8 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.769 2.313 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' NH1' ' HB1' ' A' ' 35' ' ' ALA . 14.6 mtt-85 -126.75 141.92 51.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -56.39 -33.58 65.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.424 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' TYR . . . -47.88 -42.72 22.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 52.05 71.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 0.0 109.347 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD22 ' CG1' ' A' ' 105' ' ' VAL . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.446 ' SD ' ' HA2' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.444 ' O ' HD23 ' A' ' 93' ' ' LEU . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CZ ' ' CD1' ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.548 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 79' ' ' THR . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.509 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD22 ' HG3' ' A' ' 69' ' ' MET . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 69' ' ' MET . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' CG1' ' HB3' ' A' ' 42' ' ' LEU . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' O ' ' O ' ' A' ' 39' ' ' GLY . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.509 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 94' ' ' ASN . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.631 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.512 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.512 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 90' ' ' VAL . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.96 144.53 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -126.34 145.3 50.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 64.3 mttm -87.16 133.6 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.363 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.43 79.52 70.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.09 145.39 55.11 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.712 2.275 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -69.67 147.96 64.57 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.719 2.279 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -121.67 155.73 34.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.178 -0.951 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.28 148.96 21.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 -170.17 37.76 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' ND2' ' CB ' ' A' ' 86' ' ' ALA . 48.2 t-20 -152.87 88.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -1.142 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG12 HD23 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.44 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' OE2' HG21 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.422 ' SD ' HD13 ' A' ' 103' ' ' LEU . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 53' ' ' LEU . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CD2' HG13 ' A' ' 78' ' ' VAL . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.566 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.428 HG12 HG23 ' A' ' 79' ' ' THR . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.445 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.572 HG13 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 HG23 HG12 ' A' ' 65' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.526 HG21 ' CG1' ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.567 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.523 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 102' ' ' GLN . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.458 HD23 HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.62 76.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -53.14 151.53 4.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.323 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' GLN . 68.8 mttt 57.42 47.87 15.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.506 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -43.69 -58.82 4.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 111' ' ' GLN . 49.9 Cg_endo -70.49 -11.03 29.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.622 2.215 . . . . 0.0 111.632 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.482 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.993 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.012 HG13 HD21 ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.626 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE1' HD12 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.857 HG23 ' O ' ' A' ' 79' ' ' THR . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ASP . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.445 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.857 ' O ' HG23 ' A' ' 64' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.993 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.855 HG23 HD13 ' A' ' 42' ' ' LEU . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 57' ' ' ALA . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.575 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.012 HD21 HG13 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB1' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.085 HG13 HD21 ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.766 ' O ' HD12 ' A' ' 54' ' ' LEU . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 50' ' ' THR . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' CD2' HG11 ' A' ' 78' ' ' VAL . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CE2' HD21 ' A' ' 93' ' ' LEU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 65' ' ' ILE . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 58' ' ' PHE . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 64' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 86' ' ' ALA . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 96' ' ' THR . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.583 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.085 HD21 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 90' ' ' VAL . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 42' ' ' LEU . 17.5 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.991 HD21 ' HB1' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HH ' ' HG ' ' A' ' 75' ' ' CYS . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.843 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.799 ' CD2' HG11 ' A' ' 78' ' ' VAL . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HG ' ' HH ' ' A' ' 43' ' ' TYR . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 58' ' ' PHE . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.888 ' O ' HG23 ' A' ' 64' ' ' ILE . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.922 HG22 HG12 ' A' ' 105' ' ' VAL . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.691 ' CB ' HG21 ' A' ' 105' ' ' VAL . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.595 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.606 HD21 HG13 ' A' ' 44' ' ' VAL . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' N ' HD23 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 90' ' ' VAL . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.496 HG12 HG21 ' A' ' 90' ' ' VAL . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 60.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.993 HG13 HD21 ' A' ' 103' ' ' LEU . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.854 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.617 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.847 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.877 ' O ' HD12 ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 64' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.729 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.705 HG22 HG12 ' A' ' 105' ' ' VAL . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.847 HD21 ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.587 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.993 HD21 HG13 ' A' ' 44' ' ' VAL . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 103' ' ' LEU . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 90' ' ' VAL . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.264 0.554 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.988 HD21 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 1.018 HG13 HD21 ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.737 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CB ' HD11 ' A' ' 64' ' ' ILE . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.575 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.855 ' O ' HD12 ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.988 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.972 HG22 HG11 ' A' ' 105' ' ' VAL . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 96' ' ' THR . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 1.018 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.972 HG11 HG22 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 106' ' ' ASN . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.949 HD13 ' CG2' ' A' ' 90' ' ' VAL . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.432 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.751 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 50' ' ' THR . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 93' ' ' LEU . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.978 ' CD2' HG11 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.974 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.832 HD11 ' CB ' ' A' ' 58' ' ' PHE . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.958 HG22 HG11 ' A' ' 105' ' ' VAL . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.573 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.958 HG11 HG22 ' A' ' 90' ' ' VAL . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 84.8 m-20 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 107' ' ' ILE . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.5 t-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.917 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.917 HD12 ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.917 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.582 ' N ' HD13 ' A' ' 67' ' ' LEU . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.529 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 69' ' ' MET . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.803 ' O ' HD12 ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.914 ' O ' HG23 ' A' ' 64' ' ' ILE . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.085 HG22 HG11 ' A' ' 105' ' ' VAL . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 89' ' ' ALA . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.598 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 1.085 HG11 HG22 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 107' ' ' ILE . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.951 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.823 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CD2' HG11 ' A' ' 78' ' ' VAL . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.982 ' O ' HG23 ' A' ' 64' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.49 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.871 HG22 HG21 ' A' ' 105' ' ' VAL . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.823 HD11 ' O ' ' A' ' 57' ' ' ALA . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' HG11 ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.599 ' N ' HG12 ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.871 HG21 HG22 ' A' ' 90' ' ' VAL . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 39.2 t-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.779 HG13 HD21 ' A' ' 103' ' ' LEU . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 58' ' ' PHE . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 1.011 ' O ' HG23 ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 105' ' ' VAL . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.685 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 82.3 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.544 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.779 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.834 ' CG1' HG22 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.691 ' HD2' HD21 ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.981 HG13 HD21 ' A' ' 103' ' ' LEU . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.651 ' CD2' HG11 ' A' ' 78' ' ' VAL . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 65' ' ' ILE . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 68' ' ' SER . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.744 ' N ' HD13 ' A' ' 67' ' ' LEU . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.84 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 64' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 98' ' ' VAL . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.561 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.981 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.688 HG11 ' HA ' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.691 HD21 ' HD2' ' A' ' 43' ' ' TYR . 46.5 m-20 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 43.3 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.471 ' HB3' HD11 ' A' ' 54' ' ' LEU . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.912 ' O ' HD12 ' A' ' 54' ' ' LEU . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CD2' HG11 ' A' ' 78' ' ' VAL . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.577 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.882 ' CE2' HD21 ' A' ' 93' ' ' LEU . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 66' ' ' ASP . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 65' ' ' ILE . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 64' ' ' ILE . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.784 ' O ' HD12 ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 64' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.882 HD21 ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG22 ' A' ' 90' ' ' VAL . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.4 m-20 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.065 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.852 ' OE2' HG22 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.437 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 67' ' ' LEU . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 51' ' ' PRO . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.678 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.065 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 1.014 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 86' ' ' ALA . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 92' ' ' GLU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.473 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.852 HG22 ' OE2' ' A' ' 47' ' ' GLU . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 81.7 m-20 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.893 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD11 HG11 ' A' ' 98' ' ' VAL . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.931 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.906 HG11 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.931 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 90' ' ' VAL . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 107' ' ' ILE . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD12 ' A' ' 54' ' ' LEU . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.74 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD2' HG11 ' A' ' 78' ' ' VAL . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.68 ' HE2' HD21 ' A' ' 93' ' ' LEU . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' THR . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 68' ' ' SER . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.768 ' N ' HD13 ' A' ' 67' ' ' LEU . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.876 ' O ' HD12 ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.465 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.736 HG22 ' CG1' ' A' ' 105' ' ' VAL . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.811 HD12 ' HB1' ' A' ' 89' ' ' ALA . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.568 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 103' ' ' LEU . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.736 ' CG1' HG22 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 41.0 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.273 0.558 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' HB1' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' LEU . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.947 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.947 HD12 ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.645 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' HD13 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HE2' HD21 ' A' ' 93' ' ' LEU . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 79' ' ' THR . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD12 HD13 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 58' ' ' PHE . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 64' ' ' ILE . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.869 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.774 HD12 ' HB1' ' A' ' 89' ' ' ALA . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.811 HG11 HG22 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 77.9 m-20 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' HD21 ' A' ' 40' ' ' ASN . 1.2 t-20 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.609 HD21 ' CG2' ' A' ' 90' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG13 HD21 ' A' ' 103' ' ' LEU . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 53' ' ' LEU . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.597 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 93' ' ' LEU . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 58' ' ' PHE . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.004 HD23 HG23 ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.75 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.004 HG23 HD23 ' A' ' 67' ' ' LEU . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 64' ' ' ILE . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 96' ' ' THR . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 102' ' ' GLN . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.614 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.897 HD21 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.508 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 83.4 m-20 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' HB1' ' A' ' 86' ' ' ALA . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.965 HG13 HD21 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.954 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CD2' HG11 ' A' ' 78' ' ' VAL . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.449 HD12 HD13 ' A' ' 64' ' ' ILE . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 64' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.996 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.68 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.965 HD21 HG13 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.664 ' CG1' HG13 ' A' ' 90' ' ' VAL . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 109.478 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 105' ' ' VAL . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' LEU . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CE2' HD12 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.75 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.477 HD22 ' HE ' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.829 HG22 ' CG1' ' A' ' 105' ' ' VAL . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.75 HD21 ' HE2' ' A' ' 61' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.605 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 103' ' ' LEU . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.924 HD13 ' HB1' ' A' ' 86' ' ' ALA . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' A' ' 75' ' ' CYS . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 103' ' ' LEU . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.434 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' CE2' HD21 ' A' ' 93' ' ' LEU . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 67' ' ' LEU . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' HG21 ' A' ' 64' ' ' ILE . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.551 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 58' ' ' PHE . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.924 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 86' ' ' ALA . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.993 ' HB2' HG21 ' A' ' 105' ' ' VAL . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.601 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.546 HD21 HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.993 HG21 ' HB2' ' A' ' 93' ' ' LEU . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.662 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 48.2 t-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' HG22 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 54' ' ' LEU . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HD12 ' A' ' 93' ' ' LEU . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 79' ' ' THR . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ASP . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 64' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.7 HG22 HG11 ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 96' ' ' THR . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.678 HG22 ' OE2' ' A' ' 47' ' ' GLU . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.16 147.38 60.14 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -123.89 149.71 45.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -57.88 -35.46 71.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.64 -153.85 41.11 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -165.89 92.12 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.993 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.012 HG13 HD21 ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.626 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE1' HD12 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.857 HG23 ' O ' ' A' ' 79' ' ' THR . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ASP . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.445 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.857 ' O ' HG23 ' A' ' 64' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.993 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.855 HG23 HD13 ' A' ' 42' ' ' LEU . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 57' ' ' ALA . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.575 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.012 HD21 HG13 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.96 143.09 33.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -73.96 142.53 45.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.97 -39.6 86.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -73.34 138.78 78.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 113' ' ' MET . 50.1 Cg_endo -70.39 144.8 51.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.688 2.258 . . . . 0.0 111.78 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 112' ' ' PRO . 70.6 mtm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.8 -18.47 36.82 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.799 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.22 145.81 49.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.01 26.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -161.32 90.83 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 109.46 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB1' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.085 HG13 HD21 ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.766 ' O ' HD12 ' A' ' 54' ' ' LEU . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 50' ' ' THR . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' CD2' HG11 ' A' ' 78' ' ' VAL . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CE2' HD21 ' A' ' 93' ' ' LEU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 65' ' ' ILE . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 58' ' ' PHE . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 64' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 86' ' ' ALA . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 96' ' ' THR . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.583 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.085 HD21 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 90' ' ' VAL . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 109' ' ' ARG . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.97 61.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' H ' HG22 ' A' ' 107' ' ' ILE . 61.2 mtt180 -61.77 147.31 46.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -56.86 -33.33 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 39.4 mt-30 -124.39 161.0 50.34 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -70.27 143.16 47.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.754 2.303 . . . . 0.0 111.816 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.45 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.59 -21.25 34.53 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.69 2.26 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -54.76 -36.54 64.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.13 150.63 28.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -172.34 -160.65 21.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 42' ' ' LEU . 17.5 t-20 -179.95 97.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -1.113 . . . . 0.0 109.478 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.991 HD21 ' HB1' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HH ' ' HG ' ' A' ' 75' ' ' CYS . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.843 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.799 ' CD2' HG11 ' A' ' 78' ' ' VAL . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HG ' ' HH ' ' A' ' 43' ' ' TYR . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 58' ' ' PHE . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.888 ' O ' HG23 ' A' ' 64' ' ' ILE . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.922 HG22 HG12 ' A' ' 105' ' ' VAL . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.691 ' CB ' HG21 ' A' ' 105' ' ' VAL . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.595 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.606 HD21 HG13 ' A' ' 44' ' ' VAL . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' N ' HD23 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 90' ' ' VAL . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.496 HG12 HG21 ' A' ' 90' ' ' VAL . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.61 121.85 28.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -58.66 -32.76 69.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 29.0 ttpt -73.61 134.13 43.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -122.42 89.15 49.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 144.24 54.32 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.711 2.274 . . . . 0.0 111.696 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.503 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.854 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -69.84 139.29 39.61 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.702 2.268 . . . . 0.0 111.79 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -129.33 143.0 50.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HD3' ' NZ ' ' A' ' 110' ' ' LYS . 25.7 mttt -58.44 -27.68 64.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.6 -152.28 31.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 60.5 t-20 -162.08 91.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 109.424 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.993 HG13 HD21 ' A' ' 103' ' ' LEU . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.854 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.617 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.847 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.877 ' O ' HD12 ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 64' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.729 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.705 HG22 HG12 ' A' ' 105' ' ' VAL . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.847 HD21 ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.587 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.993 HD21 HG13 ' A' ' 44' ' ' VAL . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 103' ' ' LEU . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 90' ' ' VAL . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.92 144.76 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -115.97 147.65 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.89 . . . . 0.0 109.607 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' NZ ' ' HD3' ' A' ' 38' ' ' LYS . 90.1 mttt -91.33 142.88 27.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -127.95 89.63 49.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.38 142.68 45.79 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 111.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtm . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.524 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.06 -21.1 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.752 2.302 . . . . 0.0 111.858 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -57.9 -36.25 72.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -76.5 138.14 40.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.451 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.77 -168.88 35.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 -160.74 91.82 0.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -1.151 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.988 HD21 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 1.018 HG13 HD21 ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.737 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CB ' HD11 ' A' ' 64' ' ' ILE . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.575 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.855 ' O ' HD12 ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.988 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.972 HG22 HG11 ' A' ' 105' ' ' VAL . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 96' ' ' THR . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 1.018 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.972 HG11 HG22 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 106' ' ' ASN . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.41 149.28 24.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -115.63 145.13 42.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.601 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -57.99 -37.55 74.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -84.37 128.81 60.34 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.528 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.01 145.21 55.0 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.484 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.08 -20.13 38.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.845 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.59 151.03 39.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -56.74 -32.7 65.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.388 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 -143.57 14.49 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -150.09 86.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -1.157 . . . . 0.0 109.41 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.949 HD13 ' CG2' ' A' ' 90' ' ' VAL . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.432 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.751 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 50' ' ' THR . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 93' ' ' LEU . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.978 ' CD2' HG11 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.974 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.832 HD11 ' CB ' ' A' ' 58' ' ' PHE . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.958 HG22 HG11 ' A' ' 105' ' ' VAL . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.573 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.958 HG11 HG22 ' A' ' 90' ' ' VAL . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 84.8 m-20 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 107' ' ' ILE . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.86 142.68 58.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 112' ' ' PRO . 47.5 mtt-85 -123.31 150.37 43.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -60.24 -36.57 78.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.434 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.9 79.66 73.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 109' ' ' ARG . 48.1 Cg_endo -69.2 -20.93 36.82 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.735 2.29 . . . . 0.0 111.804 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.61 146.72 62.02 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.672 2.248 . . . . 0.0 111.774 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -121.65 136.72 54.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.955 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 112' ' ' PRO . 45.7 mttm -58.93 -35.68 73.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.552 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.84 -163.2 39.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.5 t-20 -173.14 97.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 112' ' ' PRO . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.917 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.917 HD12 ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.917 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.582 ' N ' HD13 ' A' ' 67' ' ' LEU . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.529 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 69' ' ' MET . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.803 ' O ' HD12 ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.914 ' O ' HG23 ' A' ' 64' ' ' ILE . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.085 HG22 HG11 ' A' ' 105' ' ' VAL . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 89' ' ' ALA . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.598 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 1.085 HG11 HG22 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 107' ' ' ILE . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 120.89 15.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.53 -38.4 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.731 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -78.02 134.94 37.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 160.76 45.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.43 ' HB3' ' OG1' ' A' ' 41' ' ' THR . 49.4 Cg_endo -69.31 -18.46 39.13 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.739 2.293 . . . . 0.0 111.85 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.16 142.17 49.77 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.736 2.291 . . . . 0.0 111.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.14 142.26 51.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -57.92 -25.51 60.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.18 141.16 45.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 -157.77 84.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.951 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.823 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CD2' HG11 ' A' ' 78' ' ' VAL . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.982 ' O ' HG23 ' A' ' 64' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.49 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.871 HG22 HG21 ' A' ' 105' ' ' VAL . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.823 HD11 ' O ' ' A' ' 57' ' ' ALA . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' HG11 ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.599 ' N ' HG12 ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.871 HG21 HG22 ' A' ' 90' ' ' VAL . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.27 145.0 53.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -70.31 144.27 51.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -56.42 -34.62 66.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.674 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.15 102.84 54.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.549 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.5 -18.17 38.37 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.749 2.299 . . . . 0.0 111.774 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.503 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -70.24 -16.83 35.64 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.651 2.234 . . . . 0.0 111.695 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -56.7 -36.69 69.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.436 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -101.26 152.48 20.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.64 -168.68 39.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 39.2 t-20 -160.46 91.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.779 HG13 HD21 ' A' ' 103' ' ' LEU . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 58' ' ' PHE . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 1.011 ' O ' HG23 ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 105' ' ' VAL . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.685 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 82.3 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.544 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.779 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.834 ' CG1' HG22 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 109' ' ' ARG . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.65 69.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 107' ' ' ILE . 79.6 mtm-85 -119.39 149.31 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.0 -35.36 73.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.76 156.62 86.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -18.73 36.65 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.661 2.241 . . . . 0.0 111.751 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.76 147.53 63.06 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.689 2.26 . . . . 0.0 111.776 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -119.14 149.48 41.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -90.7 140.44 29.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -79.47 -166.59 32.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 179.04 100.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.142 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.691 ' HD2' HD21 ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.981 HG13 HD21 ' A' ' 103' ' ' LEU . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.651 ' CD2' HG11 ' A' ' 78' ' ' VAL . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 65' ' ' ILE . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 68' ' ' SER . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.744 ' N ' HD13 ' A' ' 67' ' ' LEU . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.84 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 64' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 98' ' ' VAL . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.981 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.688 HG11 ' HA ' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.691 HD21 ' HD2' ' A' ' 43' ' ' TYR . 46.5 m-20 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.27 147.6 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -131.87 148.01 52.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 27.4 pttt -132.3 145.42 51.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.275 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.5 70.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 110' ' ' LYS . 49.9 Cg_endo -70.27 -20.79 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.631 2.221 . . . . 0.0 111.781 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.82 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -69.63 146.15 60.09 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -118.12 154.93 31.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.0 130.15 35.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.6 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.93 -167.38 41.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 43.3 t-20 -168.2 95.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.121 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.471 ' HB3' HD11 ' A' ' 54' ' ' LEU . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.912 ' O ' HD12 ' A' ' 54' ' ' LEU . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CD2' HG11 ' A' ' 78' ' ' VAL . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.577 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.882 ' CE2' HD21 ' A' ' 93' ' ' LEU . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 66' ' ' ASP . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 65' ' ' ILE . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 64' ' ' ILE . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.784 ' O ' HD12 ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 64' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.882 HD21 ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG22 ' A' ' 90' ' ' VAL . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.4 m-20 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.95 153.99 36.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -120.46 145.43 47.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -59.22 -40.65 86.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.24 82.19 65.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 109.491 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.52 145.18 57.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 111.775 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 109.508 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -70.12 150.28 65.82 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.666 2.244 . . . . 0.0 111.802 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -58.54 -32.06 68.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.38 146.62 24.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 172.77 37.22 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 -149.5 86.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.065 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.852 ' OE2' HG22 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.437 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 67' ' ' LEU . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 51' ' ' PRO . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.678 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.065 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 1.014 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 86' ' ' ALA . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 92' ' ' GLU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.473 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.852 HG22 ' OE2' ' A' ' 47' ' ' GLU . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 81.7 m-20 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.1 147.24 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 57.5 44.91 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.353 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 19.8 tttm -56.09 -38.77 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 109.529 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.567 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 1.7 mt-30 172.03 -64.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -69.91 -19.27 35.61 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.711 2.274 . . . . 0.0 111.705 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.75 147.78 63.7 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.813 2.342 . . . . 0.0 111.824 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -115.23 146.37 41.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -58.92 -38.81 79.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.49 -174.8 50.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -161.8 92.66 0.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.348 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.893 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD11 HG11 ' A' ' 98' ' ' VAL . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.931 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.906 HG11 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.931 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 90' ' ' VAL . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 107' ' ' ILE . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -125.74 147.73 49.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -60.28 -37.93 82.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -87.39 119.63 70.89 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.437 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.73 147.49 63.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.694 2.263 . . . . 0.0 111.787 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.42 -16.69 39.15 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.772 2.314 . . . . 0.0 111.797 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -119.46 149.91 41.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' A' ' 41' ' ' THR . 40.9 mttp -62.75 -19.74 64.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.904 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 79' ' ' THR . . . 66.09 56.3 14.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 48.73 62.91 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 109.407 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 38' ' ' LYS . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD12 ' A' ' 54' ' ' LEU . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.74 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD2' HG11 ' A' ' 78' ' ' VAL . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.68 ' HE2' HD21 ' A' ' 93' ' ' LEU . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' THR . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 68' ' ' SER . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.768 ' N ' HD13 ' A' ' 67' ' ' LEU . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.876 ' O ' HD12 ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.465 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.736 HG22 ' CG1' ' A' ' 105' ' ' VAL . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.811 HD12 ' HB1' ' A' ' 89' ' ' ALA . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.568 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 103' ' ' LEU . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.736 ' CG1' HG22 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.77 147.38 50.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -129.75 148.96 51.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -56.6 -35.68 68.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 148.41 97.34 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.44 145.02 57.66 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.743 2.295 . . . . 0.0 111.786 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' ARG . 50.3 Cg_endo -69.93 143.94 51.57 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.652 2.234 . . . . 0.0 111.861 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' PRO . 63.2 mtt-85 44.51 -151.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -82.57 153.73 25.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.03 -166.0 30.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 41.0 t-20 -162.9 91.88 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' HB1' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' LEU . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.947 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.947 HD12 ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.645 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' HD13 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HE2' HD21 ' A' ' 93' ' ' LEU . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 79' ' ' THR . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD12 HD13 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 58' ' ' PHE . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 64' ' ' ILE . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.869 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.774 HD12 ' HB1' ' A' ' 89' ' ' ALA . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.811 HG11 HG22 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 77.9 m-20 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 109' ' ' ARG . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.9 70.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.61 ' H ' HG22 ' A' ' 107' ' ' ILE . 64.1 ttt-85 -117.11 144.7 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -124.05 132.06 53.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -61.38 150.62 79.66 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.497 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.94 -18.02 36.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.732 2.288 . . . . 0.0 111.763 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.17 148.36 62.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.246 . . . . 0.0 111.763 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -118.74 148.21 43.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -57.19 -35.11 69.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.25 -164.37 40.19 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' HD21 ' A' ' 40' ' ' ASN . 1.2 t-20 -155.0 88.11 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.609 HD21 ' CG2' ' A' ' 90' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG13 HD21 ' A' ' 103' ' ' LEU . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 53' ' ' LEU . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.597 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 93' ' ' LEU . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 58' ' ' PHE . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.004 HD23 HG23 ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.75 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.004 HG23 HD23 ' A' ' 67' ' ' LEU . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 64' ' ' ILE . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 96' ' ' THR . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 102' ' ' GLN . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.614 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.897 HD21 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.508 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 83.4 m-20 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 109' ' ' ARG . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.28 80.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 107' ' ' ILE . 60.4 ttt180 -100.3 140.71 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.48 -36.45 84.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.07 114.06 2.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 146.1 56.46 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.724 2.282 . . . . 0.0 111.834 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.297 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.2 Cg_endo -69.38 -14.38 37.18 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.686 2.257 . . . . 0.0 111.742 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -58.75 -33.28 70.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -60.37 -40.26 90.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -158.52 34.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -159.38 91.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' HB1' ' A' ' 86' ' ' ALA . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.965 HG13 HD21 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.954 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CD2' HG11 ' A' ' 78' ' ' VAL . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD12 HD13 ' A' ' 64' ' ' ILE . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 64' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.996 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.68 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.965 HD21 HG13 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.664 ' CG1' HG13 ' A' ' 90' ' ' VAL . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.9 51.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -145.67 169.22 18.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.923 . . . . 0.0 109.568 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -56.26 -33.77 65.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.73 80.5 24.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.84 -16.34 41.35 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.703 2.269 . . . . 0.0 111.821 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.39 -22.43 33.78 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -58.32 -34.6 70.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -60.97 -28.91 69.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.52 -172.23 42.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.653 ' OD1' ' HB3' ' A' ' 86' ' ' ALA . 0.4 OUTLIER -157.93 90.97 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.478 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 105' ' ' VAL . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' LEU . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CE2' HD12 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.75 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.477 HD22 ' HE ' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.829 HG22 ' CG1' ' A' ' 105' ' ' VAL . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.75 HD21 ' HE2' ' A' ' 61' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.605 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 103' ' ' LEU . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.84 149.75 29.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -120.26 141.52 49.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.67 146.14 50.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.363 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.38 160.62 49.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.514 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.65 145.64 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.743 2.295 . . . . 0.0 111.829 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.15 143.45 53.8 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.769 2.313 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HD2' ' CE ' ' A' ' 110' ' ' LYS . 14.6 mtt-85 -126.75 141.92 51.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -56.39 -33.58 65.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.424 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' TYR . . . -47.88 -42.72 22.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 52.05 71.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 0.0 109.347 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.924 HD13 ' HB1' ' A' ' 86' ' ' ALA . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' A' ' 75' ' ' CYS . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 103' ' ' LEU . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.434 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' CE2' HD21 ' A' ' 93' ' ' LEU . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 67' ' ' LEU . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' HG21 ' A' ' 64' ' ' ILE . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.551 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 58' ' ' PHE . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.924 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 86' ' ' ALA . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.993 ' HB2' HG21 ' A' ' 105' ' ' VAL . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.601 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.546 HD21 HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.993 HG21 ' HB2' ' A' ' 93' ' ' LEU . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.96 144.53 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -126.34 145.3 50.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.454 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 64.3 mttm -87.16 133.6 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.363 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.43 79.52 70.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.09 145.39 55.11 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.712 2.275 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -69.67 147.96 64.57 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.719 2.279 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -121.67 155.73 34.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.178 -0.951 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.28 148.96 21.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 -170.17 37.76 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.662 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 48.2 t-20 -152.87 88.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -1.142 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' HG22 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 54' ' ' LEU . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HD12 ' A' ' 93' ' ' LEU . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 79' ' ' THR . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ASP . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 64' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.7 HG22 HG11 ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 96' ' ' THR . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.678 HG22 ' OE2' ' A' ' 47' ' ' GLU . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' ARG . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.62 76.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' ILE . 12.3 mtt85 -53.14 151.53 4.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.323 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' GLN . 68.8 mttt 57.42 47.87 15.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -43.69 -58.82 4.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 111' ' ' GLN . 49.9 Cg_endo -70.49 -11.03 29.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.622 2.215 . . . . 0.0 111.632 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.482 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.248 0.547 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.993 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.012 HG13 HD21 ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.626 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE1' HD12 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.857 HG23 ' O ' ' A' ' 79' ' ' THR . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ASP . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.445 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.857 ' O ' HG23 ' A' ' 64' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.993 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.855 HG23 HD13 ' A' ' 42' ' ' LEU . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 57' ' ' ALA . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.575 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.012 HD21 HG13 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB1' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.085 HG13 HD21 ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.766 ' O ' HD12 ' A' ' 54' ' ' LEU . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 50' ' ' THR . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.708 ' CD2' HG11 ' A' ' 78' ' ' VAL . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CE2' HD21 ' A' ' 93' ' ' LEU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 65' ' ' ILE . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 58' ' ' PHE . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 64' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 86' ' ' ALA . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 96' ' ' THR . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.583 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.085 HD21 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 90' ' ' VAL . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 42' ' ' LEU . 17.5 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.991 HD21 ' HB1' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HH ' ' HG ' ' A' ' 75' ' ' CYS . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.843 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.799 ' CD2' HG11 ' A' ' 78' ' ' VAL . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HG ' ' HH ' ' A' ' 43' ' ' TYR . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 58' ' ' PHE . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.888 ' O ' HG23 ' A' ' 64' ' ' ILE . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.922 HG22 HG12 ' A' ' 105' ' ' VAL . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.691 ' CB ' HG21 ' A' ' 105' ' ' VAL . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.595 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.606 HD21 HG13 ' A' ' 44' ' ' VAL . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' N ' HD23 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 90' ' ' VAL . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.496 HG12 HG21 ' A' ' 90' ' ' VAL . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 60.5 t-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.993 HG13 HD21 ' A' ' 103' ' ' LEU . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.854 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.617 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.847 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.877 ' O ' HD12 ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 64' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.729 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.705 HG22 HG12 ' A' ' 105' ' ' VAL . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.847 HD21 ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.587 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.993 HD21 HG13 ' A' ' 44' ' ' VAL . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 103' ' ' LEU . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 90' ' ' VAL . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.264 0.554 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.988 HD21 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 1.018 HG13 HD21 ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.737 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CB ' HD11 ' A' ' 64' ' ' ILE . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.575 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.855 ' O ' HD12 ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.988 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.972 HG22 HG11 ' A' ' 105' ' ' VAL . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 96' ' ' THR . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 1.018 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.972 HG11 HG22 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 106' ' ' ASN . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.949 HD13 ' CG2' ' A' ' 90' ' ' VAL . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.432 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.751 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 50' ' ' THR . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 93' ' ' LEU . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.978 ' CD2' HG11 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.974 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.832 HD11 ' CB ' ' A' ' 58' ' ' PHE . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.958 HG22 HG11 ' A' ' 105' ' ' VAL . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.573 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.958 HG11 HG22 ' A' ' 90' ' ' VAL . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 27.8 m120 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 107' ' ' ILE . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.5 t-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.917 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.917 HD12 ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.917 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.582 ' N ' HD13 ' A' ' 67' ' ' LEU . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.529 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 69' ' ' MET . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.803 ' O ' HD12 ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.914 ' O ' HG23 ' A' ' 64' ' ' ILE . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.085 HG22 HG11 ' A' ' 105' ' ' VAL . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 89' ' ' ALA . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.598 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 1.085 HG11 HG22 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 107' ' ' ILE . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.951 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.823 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CD2' HG11 ' A' ' 78' ' ' VAL . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.982 ' O ' HG23 ' A' ' 64' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.49 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.871 HG22 HG21 ' A' ' 105' ' ' VAL . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.823 HD11 ' O ' ' A' ' 57' ' ' ALA . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' HG11 ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.599 ' N ' HG12 ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.871 HG21 HG22 ' A' ' 90' ' ' VAL . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 39.2 t-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.779 HG13 HD21 ' A' ' 103' ' ' LEU . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.6 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 58' ' ' PHE . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 1.011 ' O ' HG23 ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 105' ' ' VAL . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.685 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 28.1 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.544 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.779 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.834 ' CG1' HG22 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.981 HG13 HD21 ' A' ' 103' ' ' LEU . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.651 ' CD2' HG11 ' A' ' 78' ' ' VAL . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 65' ' ' ILE . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 68' ' ' SER . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.744 ' N ' HD13 ' A' ' 67' ' ' LEU . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.84 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 64' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 98' ' ' VAL . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.561 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.981 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.688 HG11 ' HA ' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 17.0 m120 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 43.3 t-20 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.471 ' HB3' HD11 ' A' ' 54' ' ' LEU . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.912 ' O ' HD12 ' A' ' 54' ' ' LEU . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CD2' HG11 ' A' ' 78' ' ' VAL . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.577 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.882 ' CE2' HD21 ' A' ' 93' ' ' LEU . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 66' ' ' ASP . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 65' ' ' ILE . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 64' ' ' ILE . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.784 ' O ' HD12 ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 64' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.882 HD21 ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG22 ' A' ' 90' ' ' VAL . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.9 m120 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.065 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.852 ' OE2' HG22 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.437 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 67' ' ' LEU . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 51' ' ' PRO . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.678 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.065 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 1.014 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 86' ' ' ALA . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.681 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 92' ' ' GLU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.473 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.852 HG22 ' OE2' ' A' ' 47' ' ' GLU . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 23.7 m120 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 38.5 t30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.893 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD11 HG11 ' A' ' 98' ' ' VAL . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.931 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.906 HG11 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.931 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 90' ' ' VAL . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 107' ' ' ILE . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD12 ' A' ' 54' ' ' LEU . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.74 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD2' HG11 ' A' ' 78' ' ' VAL . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.68 ' HE2' HD21 ' A' ' 93' ' ' LEU . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' THR . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 68' ' ' SER . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.768 ' N ' HD13 ' A' ' 67' ' ' LEU . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.876 ' O ' HD12 ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.465 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.736 HG22 ' CG1' ' A' ' 105' ' ' VAL . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.811 HD12 ' HB1' ' A' ' 89' ' ' ALA . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.568 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 103' ' ' LEU . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.736 ' CG1' HG22 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 41.0 t-20 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.273 0.558 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' HB1' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' LEU . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.947 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.947 HD12 ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.645 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' HD13 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HE2' HD21 ' A' ' 93' ' ' LEU . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 79' ' ' THR . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.685 HD12 HD13 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 58' ' ' PHE . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 64' ' ' ILE . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.869 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.774 HD12 ' HB1' ' A' ' 89' ' ' ALA . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.811 HG11 HG22 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 26.6 m120 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.592 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 53.3 t30 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.609 HD21 ' CG2' ' A' ' 90' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG13 HD21 ' A' ' 103' ' ' LEU . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 53' ' ' LEU . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.597 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 93' ' ' LEU . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 58' ' ' PHE . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.004 HD23 HG23 ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.75 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.004 HG23 HD23 ' A' ' 67' ' ' LEU . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 64' ' ' ILE . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.491 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 96' ' ' THR . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 102' ' ' GLN . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.614 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.897 HD21 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.508 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 23.3 m120 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' HB1' ' A' ' 86' ' ' ALA . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.965 HG13 HD21 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.954 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CD2' HG11 ' A' ' 78' ' ' VAL . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.449 HD12 HD13 ' A' ' 64' ' ' ILE . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 64' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.996 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.68 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.965 HD21 HG13 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.664 ' CG1' HG13 ' A' ' 90' ' ' VAL . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.806 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 23.6 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.299 0.571 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 105' ' ' VAL . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' LEU . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CE2' HD12 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.75 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.477 HD22 ' HE ' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.829 HG22 ' CG1' ' A' ' 105' ' ' VAL . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.75 HD21 ' HE2' ' A' ' 61' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.605 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 103' ' ' LEU . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.924 HD13 ' HB1' ' A' ' 86' ' ' ALA . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' A' ' 75' ' ' CYS . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 103' ' ' LEU . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.434 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.659 ' CE2' HD21 ' A' ' 93' ' ' LEU . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 67' ' ' LEU . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' HG21 ' A' ' 64' ' ' ILE . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.551 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 58' ' ' PHE . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.924 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 86' ' ' ALA . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.993 ' HB2' HG21 ' A' ' 105' ' ' VAL . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.601 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.546 HD21 HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.993 HG21 ' HB2' ' A' ' 93' ' ' LEU . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.662 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 48.2 t-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' HG22 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 54' ' ' LEU . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HD12 ' A' ' 93' ' ' LEU . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 79' ' ' THR . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ASP . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 64' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.7 HG22 HG11 ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 96' ' ' THR . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.678 HG22 ' OE2' ' A' ' 47' ' ' GLU . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.16 147.38 60.14 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -123.89 149.71 45.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.9 mttm -57.88 -35.46 71.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.64 -153.85 41.11 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -165.89 92.12 0.5 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.7 m -90.02 138.61 31.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.274 -0.891 . . . . 0.0 109.368 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.993 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.1 mt -106.79 145.18 32.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.905 . . . . 0.0 109.489 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.7 t80 -92.93 121.07 33.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.012 HG13 HD21 ' A' ' 103' ' ' LEU . 54.7 t -112.12 133.83 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.544 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 63.1 t80 -131.93 147.54 52.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.912 . . . . 0.0 109.448 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.5 45.58 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -112.0 152.92 27.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -1.131 . . . . 0.0 109.48 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.7 m-20 43.58 57.33 4.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.451 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 68.4 mtm -100.71 138.93 37.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.599 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.839 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.1 p -121.87 165.64 19.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.414 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.2 Cg_endo -69.25 -47.34 1.11 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.681 2.254 . . . . 0.0 111.88 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -40.61 77.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.372 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.3 tp -67.12 -48.99 66.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.352 -0.842 . . . . 0.0 109.29 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.839 HD12 ' O ' ' A' ' 50' ' ' THR . 3.5 mt -61.94 -47.34 85.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.409 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' O ' ' N ' ' A' ' 59' ' ' SER . 69.3 ttt180 -49.23 -42.66 41.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.275 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.01 -25.93 70.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.626 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -11.44 59.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -1.15 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' CE1' HD12 ' A' ' 93' ' ' LEU . 96.9 m-85 -133.99 -0.86 3.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.86 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.6 t -70.89 -56.44 5.84 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.609 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.5 Cg_endo -69.23 -22.86 33.91 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.581 2.188 . . . . 0.0 111.735 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 44.7 m-85 -71.83 -12.74 61.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.291 -0.881 . . . . 0.0 109.472 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 148.25 178.09 23.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -88.42 142.09 28.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -1.157 . . . . 0.0 109.407 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.857 HG23 ' O ' ' A' ' 79' ' ' THR . 55.4 mt -106.55 123.54 61.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.445 HG13 ' N ' ' A' ' 66' ' ' ASP . 24.7 pt -72.96 -31.9 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.445 ' N ' HG13 ' A' ' 65' ' ' ILE . 23.6 t70 -147.74 133.85 19.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.363 -0.836 . . . . 0.0 109.406 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tt -121.55 126.94 50.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 10.5 t -125.88 158.41 35.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.917 . . . . 0.0 109.546 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 75.5 mtp -140.84 149.47 42.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 109.282 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -124.18 99.74 36.96 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.227 -0.921 . . . . 0.0 109.564 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.604 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.46 -27.95 10.64 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.438 2.092 . . . . 0.0 113.641 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.72 -23.93 12.19 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.52 1.48 . . . . 0.0 111.918 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.8 mtm180 -115.89 0.79 13.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 79.6 m-20 62.11 40.66 11.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.49 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.25 166.12 20.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.91 . . . . 0.0 109.507 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.16 152.19 39.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.463 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.436 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 98.4 m-85 -117.84 137.57 52.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.352 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.586 HG11 ' CD1' ' A' ' 58' ' ' PHE . 39.7 t -125.46 123.41 64.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.669 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.857 ' O ' HG23 ' A' ' 64' ' ' ILE . 24.1 m -102.41 136.87 41.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.24 -0.913 . . . . 0.0 109.212 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.5 m-85 -121.63 134.02 54.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.221 -0.924 . . . . 0.0 109.636 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -67.07 -22.74 65.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.216 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -115.54 130.75 56.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 0.0 109.365 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 79.9 mtp -61.54 -25.8 67.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.586 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -73.56 -28.58 61.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -0.942 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.8 m -68.28 -30.42 69.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.433 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.993 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.99 -43.66 21.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -68.45 -35.31 77.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -73.98 -34.57 64.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.577 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.552 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.19 -33.69 38.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.313 -0.867 . . . . 0.0 109.685 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.855 HG23 HD13 ' A' ' 42' ' ' LEU . 55.7 t -70.56 -33.8 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.665 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.07 -36.26 41.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.198 -0.938 . . . . 0.0 109.59 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 74.4 mm-40 -81.83 -39.95 23.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.509 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.626 HD11 ' O ' ' A' ' 57' ' ' ALA . 33.9 mt -74.04 -37.11 64.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.318 -0.864 . . . . 0.0 109.464 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 27.4 t-20 -66.36 128.12 34.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.194 -0.941 . . . . 0.0 109.477 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.02 40.82 7.37 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 66.6 p -130.57 164.17 25.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -1.14 . . . . 0.0 109.517 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' CG ' ' O ' ' A' ' 101' ' ' VAL . 43.5 tt0 -133.97 157.38 46.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.221 -0.924 . . . . 0.0 109.534 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -102.86 -161.96 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.306 -0.871 . . . . 0.0 109.122 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.57 -20.21 7.46 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.253 -0.904 . . . . 0.0 108.825 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.69 35.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 102' ' ' GLN . 31.6 t -144.36 166.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 109.347 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.575 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.0 mt-30 -128.01 131.99 49.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.012 HD21 HG13 ' A' ' 44' ' ' VAL . 1.3 tt -104.51 159.33 15.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 25.2 mttm -133.38 131.42 40.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.818 HG11 HG22 ' A' ' 90' ' ' VAL . 60.4 t -109.66 132.92 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.179 -0.951 . . . . 0.0 109.596 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.57 174.23 10.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.4 mm -110.01 132.17 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.261 -0.899 . . . . 0.0 109.525 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.96 143.09 33.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -73.96 142.53 45.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.514 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -59.97 -39.6 86.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 0.0 109.516 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -73.34 138.78 78.26 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 113' ' ' MET . 50.1 Cg_endo -70.39 144.8 51.71 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.688 2.258 . . . . 0.0 111.78 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.409 ' O ' ' O ' ' A' ' 112' ' ' PRO . 70.6 mtm . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.8 -18.47 36.82 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.799 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.5 mtt85 -124.22 145.81 49.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.299 -0.876 . . . . 0.0 109.424 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.95 -167.01 26.44 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.608 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.6 t-20 -161.32 90.83 0.83 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.292 -1.122 . . . . 0.0 109.46 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 59.5 m -83.91 135.7 34.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.524 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.742 HD21 ' HB1' ' A' ' 86' ' ' ALA . 56.8 mt -114.32 146.77 40.08 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.254 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -93.52 123.61 36.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.465 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.085 HG13 HD21 ' A' ' 103' ' ' LEU . 47.2 t -115.0 130.81 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 109.398 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.428 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.5 t80 -122.51 153.04 39.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.91 -170.43 43.39 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.3 mt-10 -126.29 147.72 49.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -1.131 . . . . 0.0 109.401 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLU . 58.9 t0 44.14 54.49 5.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.217 -0.927 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -96.5 144.89 26.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 109.475 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.766 ' O ' HD12 ' A' ' 54' ' ' LEU . 11.8 p -115.02 161.01 31.53 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -68.77 -48.33 1.02 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.668 2.245 . . . . 0.0 111.8 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.55 -37.41 81.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.308 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.77 -46.22 86.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.361 -0.837 . . . . 0.0 109.135 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD12 ' O ' ' A' ' 50' ' ' THR . 2.2 mt -63.49 -48.1 79.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.352 -0.843 . . . . 0.0 109.173 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.2 mtt180 -48.25 -37.98 17.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.215 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.98 -28.81 61.8 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.654 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.82 -9.6 59.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -1.126 . . . . 0.0 109.413 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.708 ' CD2' HG11 ' A' ' 78' ' ' VAL . 91.7 m-85 -133.87 -0.48 3.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.798 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 3.2 t -70.95 -55.59 6.49 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.163 -0.961 . . . . 0.0 109.809 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.7 Cg_endo -69.11 -23.16 34.05 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.487 2.125 . . . . 0.0 111.882 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.685 ' CE2' HD21 ' A' ' 93' ' ' LEU . 51.4 m-85 -75.21 -14.06 60.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 109.483 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.07 179.97 28.14 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -92.99 139.23 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.542 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.889 HG23 ' O ' ' A' ' 79' ' ' THR . 47.8 mt -100.94 127.54 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.523 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 79' ' ' THR . 25.3 pt -77.98 -28.59 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 65' ' ' ILE . 59.7 t0 -148.64 133.48 18.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.335 -0.853 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tt -120.76 123.87 43.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 109.27 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 9.1 t -120.06 156.45 30.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.945 . . . . 0.0 109.613 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.487 ' SD ' HD13 ' A' ' 54' ' ' LEU . 97.2 mmm -132.24 142.76 49.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.3 OUTLIER -120.22 89.25 42.99 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.156 -0.965 . . . . 0.0 109.539 -179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.608 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.46 -28.15 10.48 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.442 2.094 . . . . 0.0 113.531 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.87 -24.55 11.39 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.508 1.472 . . . . 0.0 111.761 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 76.5 mtt85 -117.29 2.74 12.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.246 -0.909 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 76.9 m-20 62.3 40.82 10.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.147 -0.971 . . . . 0.0 109.46 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.0 m -132.72 167.84 19.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.436 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -148.39 152.34 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 94.4 m-85 -115.59 133.95 55.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 58' ' ' PHE . 18.0 t -118.53 133.81 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.908 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 64' ' ' ILE . 36.0 m -115.64 134.28 55.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.285 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.558 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 2.3 m-85 -116.35 137.37 52.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.906 . . . . 0.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -68.3 -27.14 66.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -0.917 . . . . 0.0 109.249 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -116.87 135.57 53.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.337 -0.852 . . . . 0.0 109.398 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 70.3 mtm -63.11 -27.81 69.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -69.03 -25.13 64.32 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.481 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -72.74 -28.18 62.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.742 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.14 -41.05 29.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.346 -0.847 . . . . 0.0 109.502 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -69.13 -35.58 76.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -0.87 . . . . 0.0 109.524 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -70.65 -39.0 73.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.516 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -74.19 -38.19 63.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 86' ' ' ALA . 69.6 t -66.69 -26.79 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.449 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.82 -34.61 39.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.298 -0.876 . . . . 0.0 109.498 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 93.5 mt-10 -95.19 -45.92 6.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 109.664 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.73 ' O ' HG23 ' A' ' 96' ' ' THR . 32.5 mt -63.36 -39.28 94.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 0.0 109.583 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 61.8 t-20 -66.52 131.23 45.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.542 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.49 50.55 6.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 93' ' ' LEU . 31.4 p -128.67 163.77 24.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -1.147 . . . . 0.0 109.351 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 61.4 tt0 -140.68 162.41 35.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.513 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -116.59 -161.59 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 100' ' ' SER . 97.5 mt-10 -56.35 -27.44 55.94 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.236 -0.915 . . . . 0.0 108.89 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 99' ' ' GLU . 0.7 OUTLIER -171.4 33.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.782 . . . . 0.0 109.473 179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.95 165.91 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.265 -0.897 . . . . 0.0 109.489 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.583 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.9 mt-30 -133.11 131.09 40.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.085 HD21 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -100.71 158.32 16.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.193 -0.942 . . . . 0.0 109.584 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 64.5 mttm -137.81 125.39 22.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.0 109.456 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.538 HG11 HG22 ' A' ' 90' ' ' VAL . 41.9 t -106.1 138.7 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.319 -0.863 . . . . 0.0 109.457 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 90.8 m-20 -143.89 174.0 11.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.517 HG22 ' H ' ' A' ' 109' ' ' ARG . 23.2 mm -108.5 129.12 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.453 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.97 61.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.426 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.517 ' H ' HG22 ' A' ' 107' ' ' ILE . 61.2 mtt180 -61.77 147.31 46.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.449 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -56.86 -33.33 66.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.409 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.412 ' HB3' ' HD2' ' A' ' 112' ' ' PRO . 39.4 mt-30 -124.39 161.0 50.34 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.415 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -70.27 143.16 47.58 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.754 2.303 . . . . 0.0 111.816 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.45 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.59 -21.25 34.53 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.69 2.26 . . . . 0.0 111.84 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.8 mtm-85 -54.76 -36.54 64.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -81.13 150.63 28.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.136 -0.977 . . . . 0.0 109.524 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -172.34 -160.65 21.35 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.585 ' OD1' HD21 ' A' ' 42' ' ' LEU . 17.5 t-20 -179.95 97.53 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -1.113 . . . . 0.0 109.478 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.9 m -80.15 140.31 36.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.991 HD21 ' HB1' ' A' ' 86' ' ' ALA . 53.7 mt -117.48 146.19 43.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 0.0 109.354 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.527 ' HH ' ' HG ' ' A' ' 75' ' ' CYS . 61.4 t80 -95.76 119.71 34.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.156 -0.965 . . . . 0.0 109.51 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.68 ' HB ' ' HB3' ' A' ' 76' ' ' ALA . 41.3 t -106.9 135.69 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 67.2 t80 -133.7 146.8 51.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.82 -173.1 42.14 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HA ' ' OE1' ' A' ' 47' ' ' GLU . 72.0 mm-40 -118.72 155.55 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -1.168 . . . . 0.0 109.409 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 46.02 55.99 6.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.6 mtm -99.59 139.28 35.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.583 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.843 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -118.19 165.38 16.5 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.548 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.7 Cg_endo -70.56 -57.3 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.684 2.256 . . . . 0.0 112.101 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 -33.35 71.3 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.99 -46.24 82.27 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.855 . . . . 0.0 109.189 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.843 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -65.94 -44.05 86.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 59' ' ' SER . 93.9 mtt180 -52.96 -35.44 58.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.96 -29.83 56.6 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -80.2 -12.12 59.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.26 -1.141 . . . . 0.0 109.236 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.799 ' CD2' HG11 ' A' ' 78' ' ' VAL . 69.8 m-85 -126.87 -2.17 6.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.84 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.562 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.3 t -68.15 -55.46 12.87 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.081 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.17 -24.43 38.25 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.493 2.128 . . . . 0.0 112.27 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.58 ' CE1' ' HA ' ' A' ' 89' ' ' ALA . 48.2 m-85 -71.9 -14.5 61.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.069 -1.019 . . . . 0.0 109.384 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.69 179.6 27.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -90.8 138.1 31.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -1.177 . . . . 0.0 109.458 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.888 HG23 ' O ' ' A' ' 79' ' ' THR . 53.7 mt -103.03 126.54 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.294 -0.879 . . . . 0.0 109.638 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.2 pt -94.95 -13.61 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 109.425 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.49 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 63.6 t0 -149.5 107.15 3.66 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 64' ' ' ILE . 1.9 tt -120.6 126.12 49.48 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.463 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 27.2 m -123.88 151.51 43.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.592 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.636 ' SD ' HD13 ' A' ' 54' ' ' LEU . 93.3 mmm -119.51 139.08 52.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.392 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -121.74 88.35 46.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.202 -0.936 . . . . 0.0 109.527 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.1 Cg_endo -74.53 -27.85 10.61 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.53 2.153 . . . . 0.0 113.733 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.75 -24.19 11.91 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.512 1.475 . . . . 0.0 111.809 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 52.8 mtt85 -112.79 1.42 15.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.222 -0.924 . . . . 0.0 109.741 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 82.7 m-20 62.43 42.13 9.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 109.42 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HG ' ' HH ' ' A' ' 43' ' ' TYR . 4.9 m -136.84 161.6 35.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.501 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' HB3' ' HB ' ' A' ' 44' ' ' VAL . . . -138.14 151.86 48.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.227 -0.921 . . . . 0.0 109.484 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.7 m-85 -117.32 134.32 54.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 58' ' ' PHE . 44.4 t -125.68 125.39 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.18 -0.95 . . . . 0.0 109.537 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.888 ' O ' HG23 ' A' ' 64' ' ' ILE . 77.1 m -106.8 136.21 47.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.347 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.5 m-85 -120.33 137.09 54.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.87 -26.66 67.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.4 mttp -116.01 140.93 48.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.46 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -68.68 -19.46 64.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.21 -0.931 . . . . 0.0 109.335 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -77.03 -26.34 53.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.4 m -72.29 -31.81 66.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.301 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.991 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.23 -43.97 31.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.349 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -65.77 -34.94 79.34 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -0.885 . . . . 0.0 109.44 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.21 -35.85 71.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.58 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -79.08 -39.82 32.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.539 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.922 HG22 HG12 ' A' ' 105' ' ' VAL . 85.5 t -67.94 -31.04 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.98 39.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.657 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.543 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 79.9 mt-10 -88.43 -43.43 11.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.74 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.691 ' CB ' HG21 ' A' ' 105' ' ' VAL . 31.8 mt -68.58 -41.28 79.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.186 -0.946 . . . . 0.0 109.657 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 47.0 t30 -66.73 129.04 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.176 -0.953 . . . . 0.0 109.52 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.11 39.48 7.39 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.588 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.3 p -126.55 164.28 21.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.172 -1.193 . . . . 0.0 109.596 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.456 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -133.13 163.59 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.79 -164.35 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.273 -0.892 . . . . 0.0 109.001 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 100' ' ' SER . 97.4 mt-10 -50.27 -23.2 2.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.12 -0.988 . . . . 0.0 108.883 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 79.6 p 179.33 35.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.367 -0.833 . . . . 0.0 109.379 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.6 t -140.66 166.24 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 109.421 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.595 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.6 mt-30 -128.66 127.45 42.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 109.474 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.606 HD21 HG13 ' A' ' 44' ' ' VAL . 3.4 tt -101.11 160.57 14.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' N ' HD23 ' A' ' 103' ' ' LEU . 59.6 tttt -141.03 121.17 13.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 109.39 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.922 HG12 HG22 ' A' ' 90' ' ' VAL . 46.5 t -110.23 131.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.227 -0.921 . . . . 0.0 109.583 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 68.6 m-20 -128.29 172.71 10.8 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.327 -0.858 . . . . 0.0 109.325 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.496 HG12 HG21 ' A' ' 90' ' ' VAL . 64.4 mt -123.29 130.07 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.61 121.85 28.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -58.66 -32.76 69.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 110' ' ' LYS . 29.0 ttpt -73.61 134.13 43.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -122.42 89.15 49.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.58 144.24 54.32 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.711 2.274 . . . . 0.0 111.696 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.3 mtp . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.503 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.854 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.854 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -69.84 139.29 39.61 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.702 2.268 . . . . 0.0 111.79 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -129.33 143.0 50.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.523 ' HD3' ' NZ ' ' A' ' 110' ' ' LYS . 25.7 mttt -58.44 -27.68 64.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.6 -152.28 31.87 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 60.5 t-20 -162.08 91.15 0.78 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 109.424 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 44.4 m -79.82 140.12 36.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.436 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -111.84 144.1 41.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 72.5 t80 -93.96 120.09 33.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.993 HG13 HD21 ' A' ' 103' ' ' LEU . 48.7 t -116.95 128.56 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -0.884 . . . . 0.0 109.471 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.7 t80 -122.04 147.18 46.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.895 . . . . 0.0 109.488 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.7 -178.01 45.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.2 mt-10 -114.97 149.56 37.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -1.142 . . . . 0.0 109.444 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 47' ' ' GLU . 80.9 m-20 43.71 53.53 5.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.44 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 64.5 mtm -93.08 139.73 30.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.915 . . . . 0.0 109.6 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.854 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -120.28 166.34 15.52 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 109.312 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.7 Cg_endo -69.18 -51.17 0.45 Allowed 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.571 2.18 . . . . 0.0 111.931 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -37.76 72.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.1 -50.86 52.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 0.0 109.145 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 50' ' ' THR . 3.4 mt -62.65 -46.56 87.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.354 -0.842 . . . . 0.0 109.155 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 59' ' ' SER . 38.6 ttm180 -50.01 -38.64 38.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.187 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.17 -29.6 62.2 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.617 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.43 -11.57 59.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.24 -1.153 . . . . 0.0 109.348 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CE2' HD12 ' A' ' 93' ' ' LEU . 91.7 m-85 -129.18 -1.77 5.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.497 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.66 -55.32 11.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.875 -179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -68.5 -23.57 37.19 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.519 2.146 . . . . 0.0 111.947 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.847 ' CE2' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -71.37 -17.94 62.39 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.149 -0.969 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 152.16 175.52 23.88 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -85.52 138.64 32.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.824 HG23 ' O ' ' A' ' 79' ' ' THR . 51.1 mt -102.53 125.64 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.0 pt -75.17 -29.44 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.422 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -154.73 129.58 9.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.66 132.71 55.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.356 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.477 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 13.2 t -125.64 154.42 42.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.52 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.2 mtp -135.53 142.12 45.35 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.892 . . . . 0.0 109.454 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.477 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -119.53 98.84 50.08 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.7 -27.86 10.26 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.487 2.125 . . . . 0.0 113.602 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.8 -24.81 11.24 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.602 1.535 . . . . 0.0 111.773 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 77.3 mtt180 -109.7 -1.74 17.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.5 m120 63.49 41.33 7.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.507 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 23.9 p -144.4 156.09 44.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.12 164.75 21.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' A' ' 68' ' ' SER . 96.9 m-85 -125.36 138.9 54.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.877 ' O ' HD12 ' A' ' 42' ' ' LEU . 37.3 t -122.85 134.43 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.666 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.824 ' O ' HG23 ' A' ' 64' ' ' ILE . 11.0 m -111.53 127.23 55.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.314 -0.866 . . . . 0.0 109.289 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.0 m-85 -111.6 134.07 53.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.19 -0.944 . . . . 0.0 109.749 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -61.74 -29.2 69.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.408 -0.807 . . . . 0.0 109.336 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -113.51 144.01 43.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.3 mtp -72.45 -21.01 61.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 0.0 109.399 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -73.76 -23.13 59.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.318 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 48.1 m -76.47 -31.84 58.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.86 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.729 ' HA ' HD21 ' A' ' 42' ' ' LEU . . . -75.58 -41.97 53.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.342 -0.849 . . . . 0.0 109.457 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.65 -35.22 80.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.208 -0.933 . . . . 0.0 109.504 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -70.81 -38.68 73.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.372 -0.83 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.584 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -66.95 -44.17 81.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.391 -0.818 . . . . 0.0 109.646 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.705 HG22 HG12 ' A' ' 105' ' ' VAL . 67.3 t -70.43 -28.69 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.07 -16.93 53.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.872 . . . . 0.0 109.698 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 88.5 tt0 -116.07 -53.36 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.847 HD21 ' CE2' ' A' ' 61' ' ' PHE . 48.1 mt -60.08 -33.62 72.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 109.398 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 28.1 t30 -68.36 125.12 25.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.304 -0.872 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.06 48.14 5.53 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.0 p -130.08 166.67 19.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -1.149 . . . . 0.0 109.381 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 62.7 tt0 -130.58 163.27 27.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.56 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -114.99 -163.2 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -0.844 . . . . 0.0 109.088 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 100' ' ' SER . 82.1 tt0 -51.32 -22.33 2.76 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -0.929 . . . . 0.0 108.841 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 1.7 t 178.82 36.36 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.467 -0.771 . . . . 0.0 109.371 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.6 t -143.29 165.82 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.252 -0.905 . . . . 0.0 109.534 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.587 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.6 mt-30 -121.84 123.61 42.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.162 -0.961 . . . . 0.0 109.311 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.993 HD21 HG13 ' A' ' 44' ' ' VAL . 2.2 tt -98.81 163.9 12.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' HD23 ' A' ' 103' ' ' LEU . 65.0 mttm -141.92 128.99 20.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.705 HG12 HG22 ' A' ' 90' ' ' VAL . 31.4 t -113.4 136.26 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.245 -0.909 . . . . 0.0 109.564 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 86.9 m-20 -140.72 172.53 12.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 63.7 mt -107.45 128.03 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.92 144.76 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.8 mtt85 -115.97 147.65 40.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.89 . . . . 0.0 109.607 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.523 ' NZ ' ' HD3' ' A' ' 38' ' ' LYS . 90.1 mttt -91.33 142.88 27.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -127.95 89.63 49.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.122 -0.986 . . . . 0.0 109.664 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.38 142.68 45.79 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 111.691 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.5 mtm . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.269 -0.894 . . . . 0.0 109.524 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.06 -21.1 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.752 2.302 . . . . 0.0 111.858 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -57.9 -36.25 72.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.536 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -76.5 138.14 40.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.451 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.77 -168.88 35.37 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.2 t-20 -160.74 91.82 0.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -1.151 . . . . 0.0 109.512 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.423 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 55.1 m -88.14 139.38 30.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.988 HD21 ' CB ' ' A' ' 86' ' ' ALA . 5.1 mp -110.37 141.71 43.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.921 . . . . 0.0 109.364 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.5 t80 -95.28 117.11 29.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 1.018 HG13 HD21 ' A' ' 103' ' ' LEU . 58.6 t -115.0 133.53 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 77.6 t80 -123.44 143.9 49.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.416 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.19 -175.29 46.08 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.1 mt-10 -121.21 159.21 26.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -1.118 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLU . 83.0 m-20 43.63 55.39 5.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 0.0 109.485 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.5 mtm -106.04 137.0 44.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.633 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.737 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -120.7 169.56 8.6 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.332 -0.855 . . . . 0.0 109.483 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 50' ' ' THR . 50.5 Cg_endo -70.58 -51.88 0.29 Allowed 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.799 2.333 . . . . 0.0 112.072 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.37 -40.67 68.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 tp -67.51 -49.78 61.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -59.24 -48.94 79.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.248 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 67.3 ttt-85 -51.77 -36.95 49.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.192 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.44 -30.64 58.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.484 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.28 -10.29 59.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.335 -1.097 . . . . 0.0 109.356 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CB ' HD11 ' A' ' 64' ' ' ILE . 79.2 m-85 -128.93 -2.54 5.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.534 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.575 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -68.17 -54.6 15.08 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.19 -0.943 . . . . 0.0 109.992 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.0 Cg_endo -68.91 -28.28 29.69 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.589 2.193 . . . . 0.0 111.968 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 39.3 m-85 -70.84 -10.98 60.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.252 -0.905 . . . . 0.0 109.422 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.24 177.43 25.05 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -89.61 138.4 31.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.282 -1.128 . . . . 0.0 109.445 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.583 HD11 ' CB ' ' A' ' 58' ' ' PHE . 70.7 mt -102.07 120.85 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 109.543 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.459 HD11 HG21 ' A' ' 79' ' ' THR . 19.5 pt -75.46 -28.55 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.452 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -154.29 142.14 20.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.268 -0.895 . . . . 0.0 109.38 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.55 129.55 49.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.427 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 77' ' ' PHE . 7.5 t -123.56 157.17 34.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.508 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.9 mtp -138.88 143.53 38.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -121.24 98.1 47.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.3 Cg_endo -74.46 -28.15 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.419 2.079 . . . . 0.0 113.619 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.87 -23.82 12.06 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.51 1.473 . . . . 0.0 111.803 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.4 mtt-85 -112.44 -0.81 15.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 0.0 109.711 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.3 m-20 62.71 41.5 9.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 109.482 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 25.4 p -140.07 159.16 42.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.955 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -134.06 163.44 29.57 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.56 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 97.8 m-85 -125.99 137.73 53.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 0.0 109.401 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.855 ' O ' HD12 ' A' ' 42' ' ' LEU . 47.9 t -122.07 132.03 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.0 109.554 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.577 ' O ' HG23 ' A' ' 64' ' ' ILE . 20.4 m -107.53 125.87 51.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.269 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.5 m-85 -111.59 134.97 52.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.606 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -60.48 -23.43 64.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 0.0 109.256 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -127.19 132.21 50.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.866 . . . . 0.0 109.417 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.8 mtm -60.41 -22.48 63.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.6 mm-40 -71.97 -24.19 61.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.905 . . . . 0.0 109.367 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 m -75.65 -28.07 58.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.163 -0.961 . . . . 0.0 109.379 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.988 ' CB ' HD21 ' A' ' 42' ' ' LEU . . . -79.29 -40.57 30.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.529 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -66.25 -35.91 81.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 109.37 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -72.29 -37.12 69.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.58 -35.22 53.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.354 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.972 HG22 HG11 ' A' ' 105' ' ' VAL . 69.5 t -71.1 -27.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -35.47 36.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.65 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 81.9 mt-10 -90.31 -42.36 11.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 109.672 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' O ' HG23 ' A' ' 96' ' ' THR . 34.0 mt -68.45 -41.17 80.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t30 -65.31 131.16 45.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 0.0 109.467 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.76 46.11 6.13 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.654 HG23 ' O ' ' A' ' 93' ' ' LEU . 28.1 p -132.29 159.58 38.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -1.186 . . . . 0.0 109.48 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 101' ' ' VAL . 60.6 tt0 -133.92 163.37 29.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 0.0 109.611 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.529 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.07 -165.41 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 109.183 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -53.96 -20.51 6.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.965 . . . . 0.0 109.076 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.1 34.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.282 -0.886 . . . . 0.0 109.545 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 102' ' ' GLN . 35.2 t -141.1 166.71 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.328 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.6 mt-30 -136.44 125.15 23.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.176 -0.953 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 1.018 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -97.35 159.2 15.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.246 -0.909 . . . . 0.0 109.497 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 33.3 mttt -140.05 130.33 25.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.194 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.972 HG11 HG22 ' A' ' 90' ' ' VAL . 61.1 t -110.39 138.92 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.18 -0.95 . . . . 0.0 109.751 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 96.7 m-20 -135.77 178.8 6.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.344 -0.848 . . . . 0.0 109.126 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 106' ' ' ASN . 24.2 mm -113.68 131.11 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.987 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -103.41 149.28 24.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 49.4 mtt-85 -115.63 145.13 42.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.17 -0.956 . . . . 0.0 109.601 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -57.99 -37.55 74.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 109.358 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -84.37 128.81 60.34 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.308 -0.87 . . . . 0.0 109.528 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.01 145.21 55.0 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.808 2.339 . . . . 0.0 111.757 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.484 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.08 -20.13 38.44 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.774 2.316 . . . . 0.0 111.845 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -120.59 151.03 39.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.952 . . . . 0.0 109.49 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -56.74 -32.7 65.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.388 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 126.18 -143.57 14.49 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -150.09 86.81 1.44 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -1.157 . . . . 0.0 109.41 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 62.4 m -78.57 135.2 37.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -0.871 . . . . 0.0 109.62 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.949 HD13 ' CG2' ' A' ' 90' ' ' VAL . 63.2 mt -108.83 149.96 28.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 109.385 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.47 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 74.0 t80 -95.16 120.68 35.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.406 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 53.9 t -120.95 136.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.49 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 79.7 t80 -122.68 147.1 46.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.606 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 174.99 177.26 43.95 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -121.63 152.67 39.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.544 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 47.18 55.89 7.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.432 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.6 mtm -107.52 143.32 36.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.583 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.751 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -118.95 164.62 20.09 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.408 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 49.1 Cg_endo -70.19 -55.24 0.17 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.763 2.309 . . . . 0.0 112.129 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -31.82 47.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.103 -0.998 . . . . 0.0 109.457 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.1 tp -72.51 -53.45 12.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.915 . . . . 0.0 109.522 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.751 HD12 ' O ' ' A' ' 50' ' ' THR . 2.8 mt -57.39 -48.41 79.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.189 -0.945 . . . . 0.0 109.652 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 64.5 mtt180 -53.61 -44.32 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.755 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' PRO . . . -61.32 -32.26 80.18 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' HD21 ' A' ' 93' ' ' LEU . . . -80.29 -47.13 15.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -1.191 . . . . 0.0 109.845 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.978 ' CD2' HG11 ' A' ' 78' ' ' VAL . 63.5 m-85 -81.94 -12.75 58.23 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.643 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.4 m -60.37 -51.58 79.1 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.345 -0.847 . . . . 0.0 109.917 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 59' ' ' SER . 51.4 Cg_endo -71.4 -24.87 22.19 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.238 1.959 . . . . 0.0 112.258 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.974 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 35.2 m-85 -76.96 -16.13 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.977 . . . . 0.0 109.685 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.95 179.03 34.46 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -93.54 127.62 39.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.366 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.832 HD11 ' CB ' ' A' ' 58' ' ' PHE . 57.4 mt -95.91 118.4 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.547 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 21.3 pt -75.25 -29.6 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.306 -0.871 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -147.04 129.31 15.7 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.459 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 55' ' ' ARG . 2.2 tt -118.06 124.71 48.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.39 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 49.2 m -121.15 146.15 47.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.956 . . . . 0.0 109.556 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 81.7 mtp -126.51 146.65 50.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.857 . . . . 0.0 109.385 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -125.67 98.14 34.87 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.14 -0.975 . . . . 0.0 109.499 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.58 -28.01 10.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.477 2.118 . . . . 0.0 113.662 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.41 -23.85 12.75 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.532 1.488 . . . . 0.0 111.986 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 70.9 mtt85 -111.28 -0.72 16.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.29 -0.882 . . . . 0.0 109.773 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.5 m-20 62.34 41.68 9.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.07 -1.019 . . . . 0.0 109.433 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . 27.6 p -143.97 155.13 43.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.171 -0.955 . . . . 0.0 109.542 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -130.48 159.31 37.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.443 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 97.2 m-85 -119.18 133.33 55.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 109.452 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 ' CD2' ' A' ' 58' ' ' PHE . 47.9 t -119.33 125.4 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.93 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 64' ' ' ILE . 56.5 m -106.21 131.84 52.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.431 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 6.5 m-85 -114.58 148.92 37.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.54 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 89.6 mt-10 -68.79 -29.53 67.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -124.54 148.45 47.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.555 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.8 mtp -68.26 -19.29 64.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.167 -0.958 . . . . 0.0 109.311 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.94 -26.71 61.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 109.39 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 24.7 m -77.17 -25.28 51.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.253 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.717 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -80.43 -41.27 24.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.424 -0.798 . . . . 0.0 109.513 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -68.95 -36.83 78.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.922 . . . . 0.0 109.587 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -71.52 -40.77 69.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.974 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -78.95 -41.22 29.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 109.449 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.958 HG22 HG11 ' A' ' 105' ' ' VAL . 99.1 t -67.51 -38.28 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -0.91 . . . . 0.0 109.615 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.96 -27.28 57.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.55 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' O ' ' CG2' ' A' ' 96' ' ' THR . 48.2 tp10 -90.13 -46.74 8.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.548 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 47.1 mt -69.8 -39.52 76.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.595 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -64.22 125.25 23.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.912 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.0 32.11 10.24 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.575 HG23 ' O ' ' A' ' 93' ' ' LEU . 22.6 p -125.08 165.41 18.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.548 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.0 tt0 -128.04 165.63 19.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.379 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.83 -161.34 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.915 . . . . 0.0 108.883 179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 100' ' ' SER . 82.2 tt0 -55.69 -19.53 11.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.185 -0.947 . . . . 0.0 108.907 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 1.4 p 177.36 35.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 109.3 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 98' ' ' VAL . 52.8 t -141.66 165.18 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.336 -0.852 . . . . 0.0 109.519 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.573 ' N ' HG12 ' A' ' 101' ' ' VAL . 88.4 mt-30 -124.79 121.62 35.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.4 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 103' ' ' LEU . 13.5 mt -90.95 123.87 34.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.193 -0.942 . . . . 0.0 109.623 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 22.0 mttm -117.53 119.78 36.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.361 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.958 HG11 HG22 ' A' ' 90' ' ' VAL . 46.8 t -106.63 150.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.727 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 27.8 m120 -148.01 174.17 12.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.314 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 107' ' ' ILE . 51.9 mt -107.48 128.16 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 0.0 109.554 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.86 142.68 58.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.316 -0.865 . . . . 0.0 109.396 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 112' ' ' PRO . 47.5 mtt-85 -123.31 150.37 43.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -60.24 -36.57 78.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -0.937 . . . . 0.0 109.434 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.9 79.66 73.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 109' ' ' ARG . 48.1 Cg_endo -69.2 -20.93 36.82 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.735 2.29 . . . . 0.0 111.804 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.5 mtm . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.244 -0.91 . . . . 0.0 109.431 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.61 146.72 62.02 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.672 2.248 . . . . 0.0 111.774 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -121.65 136.72 54.94 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.173 -0.955 . . . . 0.0 109.448 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 112' ' ' PRO . 45.7 mttm -58.93 -35.68 73.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 0.0 109.552 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.84 -163.2 39.91 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.547 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 44.5 t-20 -173.14 97.91 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.319 -1.106 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 112' ' ' PRO . 91.7 m -86.27 129.22 34.92 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.601 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.803 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.0 mp -104.1 156.15 18.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 63.4 t80 -109.13 114.79 28.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.33 139.55 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.6 t80 -128.79 138.94 52.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.33 179.53 48.86 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.19 153.21 34.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.393 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 45.67 54.61 7.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 109.409 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.5 mtm -99.82 135.96 40.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.917 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -111.51 166.14 11.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.557 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . 48.5 Cg_endo -70.55 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.78 2.32 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.5 HG23 ' NH2' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -54.52 -34.46 61.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.113 -0.992 . . . . 0.0 109.442 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -69.21 -50.22 49.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.254 -0.904 . . . . 0.0 109.478 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.917 HD12 ' O ' ' A' ' 50' ' ' THR . 1.4 mt -61.59 -41.79 97.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 mtm180 -57.66 -37.14 72.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.16 -27.12 64.72 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.917 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.33 -13.25 59.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.474 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.78 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 51.9 m-85 -129.84 -1.42 4.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.292 -0.88 . . . . 0.0 109.654 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -66.57 -55.31 19.08 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.919 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.9 -22.27 42.68 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.501 2.134 . . . . 0.0 112.131 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.591 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 43.1 m-85 -74.88 -13.14 60.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.136 -0.977 . . . . 0.0 109.676 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 153.01 -179.7 29.23 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -93.76 129.87 39.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.914 HG23 ' O ' ' A' ' 79' ' ' THR . 69.2 mt -98.34 126.53 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.7 pt -94.59 -15.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.8 t0 -146.21 106.08 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.144 -0.972 . . . . 0.0 109.638 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 67' ' ' LEU . 3.5 tm? -112.98 121.2 43.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.259 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.582 ' N ' HD13 ' A' ' 67' ' ' LEU . 41.7 m -125.71 144.1 50.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.161 -0.962 . . . . 0.0 109.668 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.529 ' HG2' ' N ' ' A' ' 70' ' ' ASP . 52.3 ttm -120.63 155.45 33.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.267 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' N ' ' HG2' ' A' ' 69' ' ' MET . 2.4 t0 -133.74 92.64 22.57 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.138 -0.976 . . . . 0.0 109.589 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.44 -27.94 10.7 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.528 2.152 . . . . 0.0 113.587 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.81 -23.83 12.14 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.458 1.439 . . . . 0.0 111.928 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 66.1 mtt180 -113.34 -0.79 14.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.791 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 64.9 m-20 63.34 43.97 5.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.496 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 12.9 m -146.2 155.94 43.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 109.551 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.7 158.83 43.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 95.0 m-85 -123.95 139.23 54.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.803 ' O ' HD12 ' A' ' 42' ' ' LEU . 51.1 t -116.79 137.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.113 -0.992 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.914 ' O ' HG23 ' A' ' 64' ' ' ILE . 64.3 m -114.68 128.1 56.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 109.319 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.9 m-85 -115.35 136.44 53.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.08 -30.72 71.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.355 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -115.61 142.31 46.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.391 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.6 mtp -67.17 -24.32 65.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.887 . . . . 0.0 109.517 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.84 -27.0 62.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.512 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.9 m -70.94 -32.87 69.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -46.69 32.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -60.98 -34.79 75.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.533 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.73 -46.89 64.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.349 -0.845 . . . . 0.0 109.667 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.965 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -63.52 -45.89 88.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.259 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.085 HG22 HG11 ' A' ' 105' ' ' VAL . 98.2 t -67.5 -23.08 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.298 -0.876 . . . . 0.0 109.182 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.14 -21.79 42.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 91.6 mt-10 -115.38 -52.08 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.965 HD12 ' HB1' ' A' ' 89' ' ' ALA . 80.3 mt -58.99 -34.44 71.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.393 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.491 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 59.0 t30 -69.73 128.25 35.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.323 -0.861 . . . . 0.0 109.443 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.28 43.82 8.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.3 p -125.45 164.41 20.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -1.146 . . . . 0.0 109.331 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.487 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.9 tt0 -128.13 164.62 22.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -124.47 -164.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 109.001 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' SER . 96.1 mt-10 -51.54 -21.77 2.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.0 108.934 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 6.3 t 178.63 34.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.398 -0.814 . . . . 0.0 109.472 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.7 t -141.76 165.97 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.598 ' N ' HG12 ' A' ' 101' ' ' VAL . 91.2 mt-30 -123.19 129.07 50.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.905 . . . . 0.0 109.464 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mt -94.46 127.37 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.229 -0.92 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 53.4 mttm -117.96 124.66 48.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.205 -0.934 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 1.085 HG11 HG22 ' A' ' 90' ' ' VAL . 31.4 t -111.09 141.7 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 109.614 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 93.9 m-20 -135.86 175.64 9.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 109.263 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 107' ' ' ILE . 56.0 mt -111.56 121.86 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.61 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 120.89 15.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.273 -0.892 . . . . 0.0 109.358 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -61.53 -38.4 87.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.302 -0.874 . . . . 0.0 109.731 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.5 tttt -78.02 134.94 37.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 160.76 45.28 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.43 ' HB3' ' OG1' ' A' ' 41' ' ' THR . 49.4 Cg_endo -69.31 -18.46 39.13 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.739 2.293 . . . . 0.0 111.85 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.6 mtp . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.16 142.17 49.77 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.736 2.291 . . . . 0.0 111.758 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.0 mtt180 -126.14 142.26 51.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -57.92 -25.51 60.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -63.18 141.16 45.93 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.49 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 54.2 t30 -157.77 84.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 77' ' ' PHE . 50.3 m -113.41 135.21 54.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.444 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 37.9 mt -99.02 148.75 23.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -0.931 . . . . 0.0 109.536 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.452 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.3 t80 -95.02 119.28 33.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.64 137.04 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.635 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 61.3 t80 -127.66 150.89 49.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.254 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' N ' ' CE ' ' A' ' 49' ' ' MET . . . 160.34 168.34 22.14 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' ASP . 21.0 pt-20 -102.83 170.04 8.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -1.143 . . . . 0.0 109.49 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' GLU . 66.4 m-20 43.41 65.06 1.05 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 109.418 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.535 ' CE ' ' N ' ' A' ' 46' ' ' GLY . 48.4 mtt -91.96 134.17 35.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.951 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -122.33 154.67 62.4 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.363 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 50' ' ' THR . 48.4 Cg_endo -70.69 -56.24 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.615 2.21 . . . . 0.0 111.862 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -32.46 72.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.0 109.287 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.0 tp -68.8 -49.82 55.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.342 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.951 HD12 ' O ' ' A' ' 50' ' ' THR . 1.7 mt -59.11 -51.26 70.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.329 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' O ' ' N ' ' A' ' 59' ' ' SER . 55.9 mtp180 -51.36 -36.51 43.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.24 -31.21 59.65 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.823 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.14 -8.7 59.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -1.092 . . . . 0.0 109.619 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' CD2' HG11 ' A' ' 78' ' ' VAL . 47.8 m-85 -133.34 -0.74 3.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.88 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -69.76 -56.36 7.83 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.113 -0.992 . . . . 0.0 109.904 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.3 Cg_endo -67.76 -22.19 43.67 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.569 2.179 . . . . 0.0 112.142 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.732 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.1 m-85 -73.32 -7.87 53.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.577 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 139.37 174.14 13.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -80.38 139.17 36.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.304 -1.116 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 79' ' ' THR . 81.5 mt -102.5 126.25 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 9.5 tt -67.04 -47.23 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.368 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' ILE . 59.1 t0 -145.57 142.18 28.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.346 -0.846 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tt -121.56 127.44 50.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.893 . . . . 0.0 109.371 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 47.3 m -122.65 148.96 44.66 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.585 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.2 mtp -128.88 143.34 50.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -123.74 95.03 45.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.218 -0.926 . . . . 0.0 109.466 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -74.74 -27.97 10.07 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.531 2.154 . . . . 0.0 113.762 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.83 -24.31 11.68 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 121.502 1.468 . . . . 0.0 111.941 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 96.1 mtt180 -111.74 0.44 16.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.819 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 19.4 m120 63.22 41.74 7.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.172 -0.955 . . . . 0.0 109.582 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 24.5 p -144.64 164.0 32.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.953 . . . . 0.0 109.466 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -144.1 158.27 43.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HB3' HG21 ' A' ' 41' ' ' THR . 99.5 m-85 -117.85 134.53 54.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.384 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -121.49 130.22 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.156 -0.965 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.982 ' O ' HG23 ' A' ' 64' ' ' ILE . 10.3 m -112.01 136.46 51.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 4.5 m-85 -117.74 126.04 51.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.567 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB ' ' A' ' 65' ' ' ILE . 96.1 mt-10 -57.58 -27.3 62.57 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.202 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -110.97 140.64 45.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.357 -0.839 . . . . 0.0 109.404 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.49 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 63.9 mtt -68.07 -30.9 70.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.172 -0.955 . . . . 0.0 109.487 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.95 -26.26 62.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.923 . . . . 0.0 109.554 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.464 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 66.5 m -68.49 -32.05 71.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.507 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -77.56 -50.32 12.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.427 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -60.39 -34.95 74.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.497 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -67.69 -44.46 77.71 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.344 -0.847 . . . . 0.0 109.607 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.42 -45.38 84.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 0.0 109.299 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.871 HG22 HG21 ' A' ' 105' ' ' VAL . 58.1 t -65.86 -23.26 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.248 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.08 -27.77 39.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.591 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 96.0 mt-10 -108.46 -51.07 2.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.559 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.823 HD11 ' O ' ' A' ' 57' ' ' ALA . 38.4 mt -57.54 -31.59 66.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.937 . . . . 0.0 109.4 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' HG11 ' A' ' 105' ' ' VAL . 56.7 t-20 -70.76 124.36 24.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.56 46.21 6.15 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 50.4 p -126.21 157.64 37.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.25 -1.147 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.0 tt0 -130.28 162.6 28.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.496 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.48 -166.31 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.08 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -50.5 -22.22 1.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.024 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.67 35.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.346 -0.846 . . . . 0.0 109.515 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 102' ' ' GLN . 46.7 t -139.84 165.88 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.561 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.599 ' N ' HG12 ' A' ' 101' ' ' VAL . 83.6 mt-30 -130.11 123.42 30.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 13.6 mt -92.82 124.68 36.99 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 69.9 mttt -114.11 128.9 56.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.871 HG21 HG22 ' A' ' 90' ' ' VAL . 9.6 p -111.12 141.23 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.194 -0.941 . . . . 0.0 109.687 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 29.1 m120 -137.6 177.02 8.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.843 . . . . 0.0 109.371 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.01 132.84 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.176 -0.953 . . . . 0.0 109.516 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.27 145.0 53.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -70.31 144.27 51.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -56.42 -34.62 66.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.674 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.15 102.84 54.79 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.931 . . . . 0.0 109.549 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.5 -18.17 38.37 Favored 'Trans proline' 0 C--O 1.214 -0.676 0 C-N-CA 122.749 2.299 . . . . 0.0 111.774 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.2 mtm . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.503 179.894 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.9 Cg_endo -70.24 -16.83 35.64 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 122.651 2.234 . . . . 0.0 111.695 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -56.7 -36.69 69.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.261 -0.899 . . . . 0.0 109.436 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -101.26 152.48 20.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.468 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 178.64 -168.68 39.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.506 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 39.2 t-20 -160.46 91.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -1.173 . . . . 0.0 109.513 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 83.4 m -76.11 135.98 39.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.519 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 86' ' ' ALA . 40.0 mt -114.62 150.3 35.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.229 -0.919 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 71.7 t80 -98.76 119.46 37.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 109.408 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.779 HG13 HD21 ' A' ' 103' ' ' LEU . 42.7 t -117.45 131.88 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.606 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 76.4 t80 -128.47 145.6 51.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' N ' ' SD ' ' A' ' 49' ' ' MET . . . -179.83 171.8 43.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.3 pt-20 -97.76 143.61 28.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.262 -1.14 . . . . 0.0 109.411 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' GLU . 81.7 m-20 43.91 56.95 4.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.445 ' SD ' ' N ' ' A' ' 46' ' ' GLY . 68.5 mtm -91.01 138.59 31.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.562 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.639 ' O ' HD12 ' A' ' 54' ' ' LEU . 1.2 p -120.41 165.26 18.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.339 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.3 Cg_endo -69.87 -55.76 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.625 2.217 . . . . 0.0 111.899 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -37.83 62.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -67.3 -49.01 65.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.274 -0.891 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' O ' ' A' ' 50' ' ' THR . 6.2 mt -64.99 -43.25 93.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 58.0 ttp180 -52.49 -39.34 61.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.319 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.29 -30.21 59.04 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -79.28 -11.76 59.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -1.102 . . . . 0.0 109.418 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 76.9 m-85 -129.19 -1.71 5.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.543 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -68.22 -56.68 10.31 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 109.965 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.5 Cg_endo -68.4 -23.06 38.41 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.55 2.167 . . . . 0.0 111.778 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 46.0 m-85 -69.31 -20.52 63.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.333 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.87 -175.4 34.41 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -95.02 133.23 39.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -1.131 . . . . 0.0 109.484 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.011 HG23 ' O ' ' A' ' 79' ' ' THR . 56.1 mt -102.35 131.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.429 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.0 pt -94.95 -18.29 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 109.335 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -147.01 112.12 5.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 tt -118.97 118.53 31.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.299 -0.875 . . . . 0.0 109.268 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 33.5 m -123.84 156.28 36.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.668 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.4 mtp -133.96 143.39 48.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 11.0 m-20 -119.28 99.23 50.51 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.179 -0.951 . . . . 0.0 109.577 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.6 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.63 -28.02 10.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.474 2.116 . . . . 0.0 113.7 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.6 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.64 -25.63 10.71 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 121.482 1.455 . . . . 0.0 111.787 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 48.7 mtt180 -109.72 -2.2 17.54 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.321 -0.862 . . . . 0.0 109.727 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 70.2 m-20 63.41 42.72 6.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.546 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.441 ' SG ' ' HB2' ' A' ' 70' ' ' ASP . 19.3 p -141.86 160.56 39.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -0.843 . . . . 0.0 109.418 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.24 155.92 46.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.14 134.73 55.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.335 -0.853 . . . . 0.0 109.426 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 58' ' ' PHE . 39.2 t -121.69 125.26 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 1.011 ' O ' HG23 ' A' ' 64' ' ' ILE . 39.5 m -108.04 138.82 43.63 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.319 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.463 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 6.7 m-85 -118.8 136.35 54.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -59.46 -30.31 68.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.276 -0.89 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -116.69 145.0 43.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 109.37 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 69.7 mtm -70.45 -18.54 62.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.38 -25.52 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.608 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 21.7 m -75.89 -32.45 59.68 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 109.499 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.46 -42.84 52.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -64.83 -35.03 79.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.272 -0.892 . . . . 0.0 109.417 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -70.9 -35.14 72.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.398 -0.814 . . . . 0.0 109.527 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -76.33 -36.46 58.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.629 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.834 HG22 ' CG1' ' A' ' 105' ' ' VAL . 73.2 t -76.03 -26.9 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.23 -29.31 38.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.915 . . . . 0.0 109.664 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.569 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 85.8 tt0 -94.74 -53.64 3.79 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.685 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 32.8 mt -60.26 -36.71 78.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 45.8 t30 -76.24 126.62 31.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.474 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.73 13.98 57.31 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 45.8 p -133.64 161.37 34.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -1.116 . . . . 0.0 109.369 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 102' ' ' GLN . 28.1 mt-30 -114.31 174.77 5.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.887 . . . . 0.0 109.585 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -100.5 -159.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -46.96 -26.21 0.95 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 6.0 p 179.47 36.53 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.66 -0.65 . . . . 0.0 109.278 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.544 HG12 ' N ' ' A' ' 102' ' ' GLN . 55.6 t -140.52 162.46 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.544 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.3 mt-30 -108.29 128.21 54.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.314 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.779 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.04 158.68 16.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 109.446 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 81.3 mttt -129.96 123.42 30.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.479 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.834 ' CG1' HG22 ' A' ' 90' ' ' VAL . 40.9 t -117.52 134.84 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.458 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 78.5 m-20 -131.61 171.81 13.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 109' ' ' ARG . 43.7 mt -113.25 137.48 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.462 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.28 -28.65 69.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.397 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 107' ' ' ILE . 79.6 mtm-85 -119.39 149.31 42.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.336 -0.853 . . . . 0.0 109.385 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.0 -35.36 73.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.76 156.62 86.46 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -18.73 36.65 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.661 2.241 . . . . 0.0 111.751 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.76 147.53 63.06 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.689 2.26 . . . . 0.0 111.776 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -119.14 149.48 41.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.306 -0.871 . . . . 0.0 109.477 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -90.7 140.44 29.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . -79.47 -166.59 32.6 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 14.1 t-20 179.04 100.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.258 -1.142 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 m -87.33 139.91 30.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.327 -0.858 . . . . 0.0 109.537 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.1 mp -111.35 153.54 25.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.918 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 69.1 t80 -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 109.407 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.981 HG13 HD21 ' A' ' 103' ' ' LEU . 58.3 t -109.06 137.65 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.218 -0.926 . . . . 0.0 109.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 73.7 t80 -131.22 148.98 52.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.52 -173.8 44.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 48' ' ' ASP . 95.2 mt-10 -121.35 154.86 35.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -1.107 . . . . 0.0 109.402 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.1 m-20 44.1 55.31 5.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.1 mtm -103.82 143.65 32.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 109.591 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -120.44 163.84 26.42 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.0 109.386 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 46.8 Cg_endo -68.48 -51.85 0.51 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.657 2.238 . . . . 0.0 111.799 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -39.11 75.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.28 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.65 -44.49 93.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -0.869 . . . . 0.0 109.232 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 50' ' ' THR . 6.7 mt -63.68 -46.6 84.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.211 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 59' ' ' SER . 23.9 mtp-105 -50.47 -37.58 39.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 0.0 109.25 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.13 -30.72 58.57 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.06 -10.18 59.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -1.125 . . . . 0.0 109.319 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.651 ' CD2' HG11 ' A' ' 78' ' ' VAL . 80.3 m-85 -130.01 -0.97 4.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 0.0 109.567 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.1 m -68.63 -54.41 13.8 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 110.084 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 59' ' ' SER . 47.2 Cg_endo -68.24 -25.25 36.96 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.51 2.14 . . . . 0.0 112.088 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.8 m-85 -72.6 -14.71 61.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 109.39 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.8 171.93 18.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -81.42 143.17 32.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -1.097 . . . . 0.0 109.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 79' ' ' THR . 65.6 mt -104.67 124.27 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.194 -0.941 . . . . 0.0 109.416 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 79' ' ' THR . 26.0 pt -82.77 -27.82 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.225 -0.922 . . . . 0.0 109.552 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.406 ' N ' HG13 ' A' ' 65' ' ' ILE . 58.1 t0 -148.16 118.55 7.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.199 -0.938 . . . . 0.0 109.572 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.744 HD13 ' N ' ' A' ' 68' ' ' SER . 3.0 tm? -111.45 123.82 51.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.324 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.744 ' N ' HD13 ' A' ' 67' ' ' LEU . 22.4 t -126.1 152.41 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.63 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.8 mtp -129.21 147.0 51.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.468 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -121.26 97.33 47.61 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.543 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.597 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.0 Cg_endo -74.62 -28.03 10.25 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.488 2.126 . . . . 0.0 113.631 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.48 -24.24 12.27 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.577 1.518 . . . . 0.0 111.759 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 88.2 mtt180 -111.53 0.91 16.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 80.6 m-20 62.44 40.74 10.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.131 -0.981 . . . . 0.0 109.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.471 ' O ' ' N ' ' A' ' 70' ' ' ASP . 30.1 p -144.21 160.12 41.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -133.65 162.69 31.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 94.8 m-85 -120.19 141.62 49.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.84 ' O ' HD12 ' A' ' 42' ' ' LEU . 45.6 t -123.29 133.35 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.283 -0.885 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.626 ' O ' HG23 ' A' ' 64' ' ' ILE . 66.5 m -111.45 126.17 54.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.551 ' HH ' ' HD2' ' A' ' 58' ' ' PHE . 3.1 m-85 -112.15 148.84 33.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.9 mt-10 -69.76 -30.63 68.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.255 -0.903 . . . . 0.0 109.233 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -118.11 137.64 52.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.866 . . . . 0.0 109.272 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.4 mtp -62.05 -24.74 67.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.528 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -30.08 68.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.182 -0.949 . . . . 0.0 109.544 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.2 m -68.79 -28.08 66.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.21 -38.43 35.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.258 -0.901 . . . . 0.0 109.591 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -71.45 -34.98 70.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.234 -0.916 . . . . 0.0 109.546 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -74.1 -34.97 64.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.362 -0.836 . . . . 0.0 109.602 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HA ' ' CE1' ' A' ' 61' ' ' PHE . . . -80.37 -26.94 38.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 109.466 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 86' ' ' ALA . 53.2 t -73.5 -39.78 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.361 -0.837 . . . . 0.0 109.644 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.62 -36.04 52.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.234 -0.917 . . . . 0.0 109.669 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.563 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 61.7 mm-40 -76.81 -43.6 35.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.602 ' CD1' ' CZ ' ' A' ' 58' ' ' PHE . 25.2 mt -72.54 -41.06 66.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 39.5 t30 -60.04 127.02 29.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.6 43.95 7.57 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 93' ' ' LEU . 40.1 p -131.45 160.75 34.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.471 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.69 149.22 47.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -98.16 -163.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.273 -0.892 . . . . 0.0 109.078 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' C ' ' O ' ' A' ' 98' ' ' VAL . 45.0 tp10 -47.14 -25.93 1.0 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.155 -0.966 . . . . 0.0 108.573 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 t -179.85 36.77 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.51 -0.744 . . . . 0.0 109.329 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 98' ' ' VAL . 46.2 t -142.22 164.51 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.622 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.8 mt-30 -116.21 134.26 55.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.139 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.981 HD21 HG13 ' A' ' 44' ' ' VAL . 1.1 tt -107.3 157.96 17.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.689 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 19.8 mttt -133.12 134.05 43.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.267 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.688 HG11 ' HA ' ' A' ' 90' ' ' VAL . 58.9 t -112.44 139.61 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.751 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.461 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 17.0 m120 -142.05 163.27 33.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.883 . . . . 0.0 109.149 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 tt -103.29 133.0 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.712 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.27 147.6 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.0 109.377 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -131.87 148.01 52.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.599 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.417 ' HG3' ' HD3' ' A' ' 112' ' ' PRO . 27.4 pttt -132.3 145.42 51.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.275 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.72 74.5 70.21 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.623 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HG3' ' A' ' 110' ' ' LYS . 49.9 Cg_endo -70.27 -20.79 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.631 2.221 . . . . 0.0 111.781 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.289 -0.882 . . . . 0.0 109.502 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.82 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.82 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -69.63 146.15 60.09 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.836 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.5 mtt85 -118.12 154.93 31.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -89.0 130.15 35.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.249 -0.907 . . . . 0.0 109.6 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.93 -167.38 41.95 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 43.3 t-20 -168.2 95.59 0.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -1.121 . . . . 0.0 109.311 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.7 m -84.87 131.92 34.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.841 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -106.7 156.27 18.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.8 t80 -108.8 107.4 17.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.528 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.3 t -102.18 145.79 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.877 . . . . 0.0 109.441 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.454 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 68.5 t80 -136.64 141.97 43.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.412 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.98 -177.58 48.38 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -122.16 150.21 42.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -1.111 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 47.48 56.96 6.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.471 ' HB3' HD11 ' A' ' 54' ' ' LEU . 61.9 mtm -103.85 140.69 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.498 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.912 ' O ' HD12 ' A' ' 54' ' ' LEU . 34.3 p -114.07 161.03 30.12 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.384 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.4 Cg_endo -69.14 -54.08 0.27 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.693 2.262 . . . . 0.0 111.951 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.56 -35.83 66.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.322 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.2 tp -68.71 -50.7 48.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.39 -0.819 . . . . 0.0 109.319 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.912 HD12 ' O ' ' A' ' 50' ' ' THR . 1.6 mt -62.19 -45.2 94.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.239 -0.913 . . . . 0.0 109.321 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 ttt180 -51.33 -41.95 60.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.76 -27.14 71.37 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.593 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.11 -22.48 42.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -1.124 . . . . 0.0 109.424 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CD2' HG11 ' A' ' 78' ' ' VAL . 31.9 m-85 -117.85 -0.63 11.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.568 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.577 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.5 t -68.47 -54.58 13.99 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.253 -0.905 . . . . 0.0 110.24 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.8 Cg_endo -67.96 -23.12 41.08 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.49 2.126 . . . . 0.0 112.155 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.882 ' CE2' HD21 ' A' ' 93' ' ' LEU . 61.5 m-85 -75.07 -11.96 60.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.48 174.99 22.82 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -90.95 130.12 36.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 79' ' ' THR . 46.0 mt -94.5 125.39 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.9 . . . . 0.0 109.458 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 66' ' ' ASP . 26.8 pt -84.52 -27.09 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 65' ' ' ILE . 60.5 t0 -149.21 113.18 5.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.532 HD12 HD13 ' A' ' 64' ' ' ILE . 2.0 tt -107.76 130.95 54.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.886 . . . . 0.0 109.345 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 t -123.14 153.28 40.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.177 -0.952 . . . . 0.0 109.579 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 85.2 mtp -130.87 135.74 47.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.33 -0.856 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -115.29 94.85 40.76 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.606 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.5 Cg_endo -74.66 -28.02 10.19 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.577 2.185 . . . . 0.0 113.629 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 54.8 Cg_endo -75.57 -24.24 12.14 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 121.45 1.434 . . . . 0.0 111.78 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 94.5 mtt-85 -111.01 0.14 16.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 109.556 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.5 m-20 62.85 41.31 8.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.175 -0.953 . . . . 0.0 109.491 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 31.3 p -143.62 160.6 40.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.518 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.15 155.68 47.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 109.489 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 79.8 m-85 -115.61 143.63 45.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.894 . . . . 0.0 109.392 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.784 ' O ' HD12 ' A' ' 42' ' ' LEU . 42.0 t -122.35 131.73 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.749 ' O ' HG23 ' A' ' 64' ' ' ILE . 29.1 m -110.14 129.15 55.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.948 . . . . 0.0 109.341 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 3.9 m-85 -117.21 134.33 54.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.939 . . . . 0.0 109.58 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.66 -26.47 68.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -118.27 139.94 50.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.277 -0.889 . . . . 0.0 109.304 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.7 mtt -68.0 -21.47 65.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -72.25 -27.44 62.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.955 . . . . 0.0 109.397 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.3 m -72.7 -30.81 64.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.577 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -76.48 -39.23 53.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.521 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.89 -35.21 79.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.303 -0.873 . . . . 0.0 109.548 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -70.19 -44.28 69.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.326 -0.859 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -62.79 -42.29 99.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.336 -0.853 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.554 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -69.47 -25.31 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 0.0 109.455 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.35 -20.37 44.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 109.662 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.551 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -120.02 -55.81 2.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.2 -0.937 . . . . 0.0 109.642 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.882 HD21 ' CE2' ' A' ' 61' ' ' PHE . 29.3 mt -56.54 -26.67 55.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 0.0 109.327 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 43.4 t-20 -77.34 122.1 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.96 48.69 4.79 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 43.5 p -126.84 160.82 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -1.151 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.4 tt0 -128.6 163.11 25.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.527 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -128.06 -164.0 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 109.202 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' C ' ' OG ' ' A' ' 100' ' ' SER . 95.9 mt-10 -51.87 -21.93 3.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -0.955 . . . . 0.0 108.985 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' C ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER 178.2 36.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 0.0 109.452 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.32 162.36 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.226 -0.922 . . . . 0.0 109.546 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.539 ' N ' HG12 ' A' ' 101' ' ' VAL . 93.2 mt-30 -124.52 121.25 34.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.5 mt -90.68 122.2 33.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.291 -0.881 . . . . 0.0 109.646 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 53.0 tttp -120.69 122.69 40.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 0.0 109.233 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.554 HG11 HG22 ' A' ' 90' ' ' VAL . 38.7 t -109.3 148.13 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.765 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 105' ' ' VAL . 21.9 m120 -141.67 -176.21 4.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.166 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 25.9 mm -112.01 127.94 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.583 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.95 153.99 36.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.32 -0.862 . . . . 0.0 109.336 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -120.46 145.43 47.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -59.22 -40.65 86.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.506 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.24 82.19 65.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.155 -0.966 . . . . 0.0 109.491 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.52 145.18 57.71 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.705 2.27 . . . . 0.0 111.775 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.0 109.508 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.632 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.632 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 50.0 Cg_endo -70.12 150.28 65.82 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.666 2.244 . . . . 0.0 111.802 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -58.54 -32.06 68.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.3 mttt -89.38 146.62 24.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.211 -0.931 . . . . 0.0 109.41 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.13 172.77 37.22 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 86' ' ' ALA . 13.5 t-20 -149.5 86.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.44 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 34.0 m -62.71 139.38 58.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.065 HD21 ' HB1' ' A' ' 86' ' ' ALA . 74.4 mt -116.52 133.94 55.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.469 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.4 t80 -85.83 121.24 28.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.469 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG11 HD22 ' A' ' 54' ' ' LEU . 61.8 t -119.11 134.55 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 73.4 t80 -133.87 146.76 50.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 109.407 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 167.7 169.33 31.09 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.852 ' OE2' HG22 ' A' ' 101' ' ' VAL . 23.2 pt-20 -97.12 152.41 18.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.221 -1.164 . . . . 0.0 109.49 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 46.0 58.43 4.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.464 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.437 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 65.8 mtm -105.16 141.73 36.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.89 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -121.18 160.78 43.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.475 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HA ' HD21 ' A' ' 67' ' ' LEU . 48.6 Cg_endo -70.58 -56.57 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.697 2.264 . . . . 0.0 112.049 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -36.56 76.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.972 . . . . 0.0 109.389 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.2 tp -64.23 -43.41 95.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 109.273 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.554 HD22 HG11 ' A' ' 44' ' ' VAL . 14.6 mt -67.02 -39.21 87.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.291 -0.881 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' SER . 74.4 ttt180 -56.75 -37.11 70.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.242 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.404 ' O ' ' CD ' ' A' ' 60' ' ' PRO . . . -70.34 -38.81 70.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -75.65 -30.56 59.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.411 -1.052 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.681 ' CZ ' HD12 ' A' ' 93' ' ' LEU . 57.1 m-85 -99.56 -3.92 32.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.339 -0.851 . . . . 0.0 109.409 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -66.64 -52.73 32.82 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.6 Cg_endo -68.17 -34.12 22.94 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.378 2.052 . . . . 0.0 112.059 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 28.7 m-85 -65.34 -31.8 73.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.1 -1.0 . . . . 0.0 109.259 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 85' ' ' SER . . . -178.96 -174.29 45.02 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -100.35 127.5 46.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.276 -1.132 . . . . 0.0 109.504 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 78' ' ' VAL . 85.4 mt -90.52 127.1 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.76 -19.0 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.897 . . . . 0.0 109.374 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 58.9 t0 -157.84 108.55 2.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.487 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 51' ' ' PRO . 52.8 tp -99.9 127.54 46.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.363 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.678 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 86.0 p -126.53 159.7 32.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.554 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 76' ' ' ALA . 84.9 mtp -132.89 157.5 44.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.904 . . . . 0.0 109.357 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.5 t0 -133.93 106.08 11.55 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.599 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.7 Cg_endo -74.44 -27.93 10.71 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.475 2.116 . . . . 0.0 113.58 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.35 -24.02 12.68 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.429 1.419 . . . . 0.0 111.768 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 74.2 mtt85 -115.42 -0.38 13.14 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.304 -0.873 . . . . 0.0 109.603 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 72.4 m-20 61.04 36.18 18.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' ASP . 27.2 p -141.02 154.98 46.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -126.44 148.54 49.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.336 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 72.1 m-85 -113.81 109.92 19.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.5 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.614 HG22 HG23 ' A' ' 64' ' ' ILE . 7.4 p -105.78 134.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.481 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' THR . 37.4 m -93.65 147.37 23.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 109.494 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -113.94 148.39 36.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.307 -0.87 . . . . 0.0 109.454 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -69.08 -35.03 76.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.412 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -120.87 143.3 48.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.383 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 90.3 mtp -70.94 -36.27 72.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.498 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.31 -38.73 92.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.41 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 61' ' ' PHE . 20.6 m -66.72 -30.58 70.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.065 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -71.96 -33.48 68.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.4 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -70.94 -36.63 72.68 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -0.914 . . . . 0.0 109.432 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -71.66 -29.83 65.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 1.014 ' HB2' ' HB3' ' A' ' 61' ' ' PHE . . . -80.06 -42.42 23.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.347 -0.846 . . . . 0.0 109.382 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 86' ' ' ALA . 58.0 t -67.77 -34.33 67.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.569 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.02 -29.76 39.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.78 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 61' ' ' PHE . 46.6 tp10 -85.37 -44.17 13.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.72 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.681 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mt -73.36 -38.83 65.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.601 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 44.0 t30 -66.11 133.21 50.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.85 41.51 10.64 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 92' ' ' GLU . 55.5 p -133.0 165.28 25.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -1.14 . . . . 0.0 109.503 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.473 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.0 tt0 -128.14 163.36 24.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.638 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -117.15 -164.63 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 0.0 109.038 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -48.46 -24.72 1.37 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.204 -0.935 . . . . 0.0 108.792 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.67 36.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.483 -0.761 . . . . 0.0 109.258 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.852 HG22 ' OE2' ' A' ' 47' ' ' GLU . 54.1 t -141.48 166.16 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.49 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.5 mt-30 -122.25 135.05 54.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.49 HD23 HG23 ' A' ' 105' ' ' VAL . 0.4 OUTLIER -106.04 159.0 16.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 29.5 tttt -143.85 113.26 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.578 HG12 HG13 ' A' ' 90' ' ' VAL . 25.8 t -109.12 141.59 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 23.7 m120 -137.25 171.1 14.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.323 -0.861 . . . . 0.0 109.305 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.5 mt -112.41 124.2 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.605 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.1 147.24 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 57.5 44.91 20.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.353 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 111' ' ' GLN . 19.8 tttm -56.09 -38.77 71.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.331 -0.856 . . . . 0.0 109.529 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.567 ' CB ' ' CD ' ' A' ' 112' ' ' PRO . 1.7 mt-30 172.03 -64.67 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.923 . . . . 0.0 109.401 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 111' ' ' GLN . 49.5 Cg_endo -69.91 -19.27 35.61 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.711 2.274 . . . . 0.0 111.705 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 86.5 mtp . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.477 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.75 147.78 63.7 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.813 2.342 . . . . 0.0 111.824 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.3 ttt-85 -115.23 146.37 41.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.446 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -58.92 -38.81 79.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.595 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.49 -174.8 50.16 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.628 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 38.5 t30 -161.8 92.66 0.87 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.293 -1.122 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 43.8 m -85.91 137.5 32.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.321 -0.862 . . . . 0.0 109.613 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 78' ' ' VAL . 5.2 mp -109.41 151.74 26.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.464 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 67.4 t80 -100.1 113.52 26.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.6 t -109.17 132.54 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 77.7 t80 -124.27 145.24 49.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.223 -0.923 . . . . 0.0 109.581 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.94 -179.55 46.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.05 151.18 40.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.129 . . . . 0.0 109.477 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 45.94 56.72 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.315 -0.866 . . . . 0.0 109.51 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -103.48 139.3 39.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.893 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -105.34 164.71 14.51 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 50.4 Cg_endo -70.04 -28.62 23.7 Favored 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.754 2.303 . . . . 0.0 111.904 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.3 p -80.11 -35.63 36.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD11 HG11 ' A' ' 98' ' ' VAL . 6.4 tt -62.32 -36.81 83.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.893 HD12 ' O ' ' A' ' 50' ' ' THR . 1.2 mt -72.07 -34.02 68.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.395 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 54.8 mtt180 -64.04 -40.56 96.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.35 -32.42 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' O ' HD21 ' A' ' 93' ' ' LEU . . . -75.78 -12.68 60.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.244 -1.15 . . . . 0.0 109.348 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.931 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 10.3 m-85 -128.8 0.1 5.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.3 -0.875 . . . . 0.0 109.479 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.569 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 1.6 t -69.22 -54.86 10.9 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 110.139 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -68.14 -22.95 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.5 2.133 . . . . 0.0 112.193 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 89' ' ' ALA . 54.3 m-85 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.514 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 154.78 177.85 28.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -87.77 141.74 28.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 79' ' ' THR . 66.7 mt -104.14 124.42 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 24.4 pt -91.8 -25.0 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.282 -0.887 . . . . 0.0 109.573 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 79' ' ' THR . 85.6 m-20 -143.29 114.6 7.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.46 129.46 55.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.318 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 50.6 m -127.5 146.4 50.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.4 mtp -127.69 148.94 50.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.485 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 75' ' ' CYS . 0.6 OUTLIER -125.66 94.2 42.92 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.2 -0.938 . . . . 0.0 109.528 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 48.0 Cg_endo -74.48 -27.85 10.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.531 2.154 . . . . 0.0 113.649 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.5 Cg_endo -75.56 -25.84 10.63 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.474 1.449 . . . . 0.0 111.762 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 21.5 mtt-85 -113.48 1.22 14.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.616 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.2 m-20 62.32 39.85 11.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -0.927 . . . . 0.0 109.465 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -133.29 157.52 45.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -137.48 152.14 49.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.335 -0.853 . . . . 0.0 109.416 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 68.2 m-85 -117.43 144.87 44.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.229 -0.919 . . . . 0.0 109.449 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.906 HG11 ' CD2' ' A' ' 58' ' ' PHE . 43.6 t -122.19 135.43 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 0.0 109.488 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 64' ' ' ILE . 87.4 m -113.5 127.88 56.25 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.435 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.2 m-85 -113.2 141.05 47.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -69.21 -24.69 64.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.302 -0.874 . . . . 0.0 109.228 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.82 134.23 55.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.388 -0.82 . . . . 0.0 109.169 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 84.2 mtp -62.27 -26.23 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.905 . . . . 0.0 109.539 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.53 -25.99 63.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 39.1 m -71.4 -28.93 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -0.909 . . . . 0.0 109.533 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.732 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.24 -41.23 28.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -67.69 -39.94 84.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 109.67 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 -68.33 -37.3 80.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.496 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.6 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -78.51 -38.89 39.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.904 . . . . 0.0 109.397 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 86' ' ' ALA . 55.9 t -60.79 -30.2 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.89 -45.43 20.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 109.516 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 61' ' ' PHE . 47.2 tp10 -79.49 -45.1 19.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.587 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.931 HD13 ' CZ ' ' A' ' 58' ' ' PHE . 75.7 mt -61.65 -35.65 78.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.731 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 49.5 t30 -67.51 122.27 17.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.192 -0.942 . . . . 0.0 109.424 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.02 57.52 2.51 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 93' ' ' LEU . 13.8 p -136.33 160.12 39.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.388 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 61.9 tt0 -130.3 167.39 18.56 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.525 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.825 HG11 HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -127.03 -161.29 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.318 -0.864 . . . . 0.0 109.013 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.01 -18.67 10.05 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.226 -0.921 . . . . 0.0 108.95 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.48 34.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.484 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.2 t -140.03 165.41 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.0 mt-30 -120.56 121.68 38.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.453 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 96' ' ' THR . 31.2 mt -93.87 122.47 36.38 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.227 -0.92 . . . . 0.0 109.692 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 31.3 tttm -117.04 118.91 33.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.255 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG11 ' HA ' ' A' ' 90' ' ' VAL . 5.2 p -100.89 142.73 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.152 -0.968 . . . . 0.0 109.696 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.535 ' O ' HD13 ' A' ' 107' ' ' ILE . 97.0 m-20 -140.21 -175.91 4.42 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.535 HD13 ' O ' ' A' ' 106' ' ' ASN . 26.7 mm -116.72 126.17 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 0.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.53 151.69 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.48 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 73.7 mtt85 -125.74 147.73 49.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -60.28 -37.93 82.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -87.39 119.63 70.89 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.437 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.73 147.49 63.2 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.694 2.263 . . . . 0.0 111.787 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -69.42 -16.69 39.15 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.772 2.314 . . . . 0.0 111.797 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -119.46 149.91 41.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' O ' ' OG1' ' A' ' 41' ' ' THR . 40.9 mttp -62.75 -19.74 64.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.904 . . . . 0.0 109.383 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 79' ' ' THR . . . 66.09 56.3 14.86 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 83' ' ' MET . 28.6 t-20 48.73 62.91 2.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -1.125 . . . . 0.0 109.407 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 38' ' ' LYS . 60.3 m -89.9 152.37 21.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.566 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.876 HD12 ' O ' ' A' ' 78' ' ' VAL . 4.7 mp -117.7 148.93 41.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.336 -0.853 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.7 t80 -100.29 114.28 27.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.93 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 t -107.22 137.0 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 74.4 t80 -128.17 146.04 50.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.65 -179.32 42.75 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -121.62 156.25 33.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.279 -1.13 . . . . 0.0 109.513 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.427 ' C ' ' O ' ' A' ' 47' ' ' GLU . 77.9 m-20 44.05 59.26 3.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.336 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 67.5 mtm -107.76 145.73 33.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.703 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.905 ' O ' HD12 ' A' ' 54' ' ' LEU . 66.9 p -115.95 161.02 33.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.341 -0.849 . . . . 0.0 109.213 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 45.8 Cg_endo -68.21 -54.37 0.32 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.569 2.179 . . . . 0.0 111.98 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -54.98 -33.18 62.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.138 -0.976 . . . . 0.0 109.298 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.1 tp -68.33 -47.63 66.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.382 -0.824 . . . . 0.0 109.329 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.905 HD12 ' O ' ' A' ' 50' ' ' THR . 1.3 mt -63.33 -38.93 93.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 59' ' ' SER . 83.1 mtp180 -61.94 -35.33 78.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.275 -0.89 . . . . 0.0 109.182 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.91 -33.25 46.65 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.74 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -76.99 -11.19 59.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.388 -1.066 . . . . 0.0 109.326 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.686 ' CD2' HG11 ' A' ' 78' ' ' VAL . 34.6 m-85 -127.4 -2.64 6.21 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.89 . . . . 0.0 109.502 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.568 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -66.51 -55.27 19.53 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.957 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.26 -23.28 39.05 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.41 2.074 . . . . 0.0 111.876 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.68 ' HE2' HD21 ' A' ' 93' ' ' LEU . 40.2 m-85 -72.73 -13.13 61.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.394 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 150.78 173.14 20.57 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -80.71 146.57 31.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -1.129 . . . . 0.0 109.33 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' THR . 75.6 mt -108.81 121.03 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 79' ' ' THR . 20.4 pt -76.88 -25.02 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.318 -0.863 . . . . 0.0 109.618 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -159.89 138.36 10.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.167 -0.958 . . . . 0.0 109.672 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.768 HD13 ' N ' ' A' ' 68' ' ' SER . 3.4 tm? -117.12 128.58 55.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.226 -0.921 . . . . 0.0 109.223 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.768 ' N ' HD13 ' A' ' 67' ' ' LEU . 10.3 t -124.9 153.07 43.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.984 . . . . 0.0 109.597 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 89.4 mtp -133.65 147.83 51.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 109.449 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -125.55 96.86 37.65 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.908 . . . . 0.0 109.535 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.7 Cg_endo -74.34 -28.21 10.64 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.517 2.145 . . . . 0.0 113.635 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.4 Cg_endo -75.43 -23.73 12.84 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.476 1.451 . . . . 0.0 111.883 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 73.4 mtp180 -112.55 -2.38 14.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.624 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 67.2 m-20 62.98 43.51 6.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.3 p -142.28 156.77 45.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.602 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.21 164.11 23.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.919 . . . . 0.0 109.581 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 93.3 m-85 -127.99 136.46 51.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.28 -0.887 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.876 ' O ' HD12 ' A' ' 42' ' ' LEU . 54.1 t -118.18 134.72 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.271 -0.893 . . . . 0.0 109.422 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 65' ' ' ILE . 7.0 m -109.8 127.12 54.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 3.6 m-85 -113.82 139.78 48.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.12 -0.988 . . . . 0.0 109.474 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -67.07 -21.67 65.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.384 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -123.71 140.27 53.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.28 -0.888 . . . . 0.0 109.534 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.465 ' HA ' ' ND2' ' A' ' 40' ' ' ASN . 46.4 ttm -67.52 -22.27 65.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.213 -0.93 . . . . 0.0 109.407 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -71.98 -25.37 61.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 32.4 m -74.35 -31.14 62.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.801 ' CA ' HD21 ' A' ' 42' ' ' LEU . . . -75.12 -43.88 50.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -62.99 -36.87 84.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -67.7 -44.66 77.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.811 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -61.89 -42.78 99.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.216 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.736 HG22 ' CG1' ' A' ' 105' ' ' VAL . 81.7 t -68.57 -25.95 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.296 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.46 -19.83 45.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.556 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 95.9 mt-10 -118.69 -56.6 2.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.811 HD12 ' HB1' ' A' ' 89' ' ' ALA . 67.8 mt -56.59 -32.92 65.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.062 -1.024 . . . . 0.0 109.376 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 49.6 t-20 -67.9 125.64 26.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.304 -0.872 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.73 53.43 4.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 93' ' ' LEU . 30.8 p -133.74 164.63 26.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -1.128 . . . . 0.0 109.468 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 60.4 tt0 -131.35 165.72 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.411 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -127.63 -161.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.288 -0.882 . . . . 0.0 108.885 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -55.18 -19.64 8.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.125 -0.984 . . . . 0.0 108.849 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 4.5 p 176.45 37.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 0.0 109.408 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 102' ' ' GLN . 44.4 t -142.4 163.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.349 -0.844 . . . . 0.0 109.538 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.568 ' N ' HG12 ' A' ' 101' ' ' VAL . 87.6 mt-30 -122.31 120.89 35.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.163 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 103' ' ' LEU . 20.8 mt -97.05 122.43 40.05 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.157 -0.964 . . . . 0.0 109.596 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 58.0 tttp -122.63 120.76 34.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.458 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.736 ' CG1' HG22 ' A' ' 90' ' ' VAL . 43.5 t -103.13 147.81 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.334 -0.854 . . . . 0.0 109.677 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 91.3 m-20 -142.06 -178.21 5.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.37 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 26.3 mm -111.41 123.57 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.178 -0.951 . . . . 0.0 109.494 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.77 147.38 50.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.537 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -129.75 148.96 51.69 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.545 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -56.6 -35.68 68.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.456 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.82 148.41 97.34 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.483 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.44 145.02 57.66 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.743 2.295 . . . . 0.0 111.786 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.446 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 37' ' ' ARG . 50.3 Cg_endo -69.93 143.94 51.57 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.652 2.234 . . . . 0.0 111.861 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 36' ' ' PRO . 63.2 mtt-85 44.51 -151.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.5 mttt -82.57 153.73 25.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.57 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.03 -166.0 30.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 41.0 t-20 -162.9 91.88 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -1.144 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 57.4 m -84.58 136.24 33.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -0.917 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' HB1' ' A' ' 86' ' ' ALA . 47.3 mt -111.77 144.58 40.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 77.9 t80 -89.38 124.51 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.9 130.79 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -0.927 . . . . 0.0 109.438 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 71.9 t80 -122.24 146.15 47.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.444 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.86 171.22 36.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.31 158.96 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.298 -1.119 . . . . 0.0 109.452 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 45.44 57.99 4.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.437 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.594 ' HB3' HD11 ' A' ' 54' ' ' LEU . 58.7 mtm -109.22 136.1 49.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -0.909 . . . . 0.0 109.542 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.947 ' O ' HD12 ' A' ' 54' ' ' LEU . 0.7 OUTLIER -120.17 166.99 13.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.228 -0.92 . . . . 0.0 109.498 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.4 Cg_endo -69.68 -55.61 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.665 2.243 . . . . 0.0 111.978 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -53.85 -35.01 61.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.33 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.9 tp -72.64 -50.28 26.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.366 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.947 HD12 ' O ' ' A' ' 50' ' ' THR . 2.6 mt -66.3 -48.38 70.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.324 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 59' ' ' SER . 36.7 ttm180 -51.66 -39.51 58.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.337 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.59 -31.06 65.69 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.645 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.22 -18.59 49.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 109.521 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.625 ' CE1' HD13 ' A' ' 93' ' ' LEU . 60.2 m-85 -118.93 -1.38 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.932 . . . . 0.0 109.526 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -69.68 -52.71 13.47 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.246 -0.909 . . . . 0.0 110.428 -179.652 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.1 Cg_endo -68.12 -22.4 41.09 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.358 2.039 . . . . 0.0 112.398 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.586 ' HE2' HD21 ' A' ' 93' ' ' LEU . 50.6 m-85 -73.66 -19.16 60.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.024 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 157.32 175.94 28.81 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -88.22 138.87 31.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.332 -1.099 . . . . 0.0 109.497 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 79' ' ' THR . 58.3 mt -102.45 126.84 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.307 -0.87 . . . . 0.0 109.513 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.8 pt -95.64 -15.99 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.427 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -147.71 98.79 3.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.485 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.685 HD12 HD13 ' A' ' 64' ' ' ILE . 2.3 tt -108.88 125.65 52.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.455 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 44.9 m -124.86 151.45 45.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.606 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 83.8 mtp -124.98 149.2 47.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.471 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.474 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 1.8 m-20 -126.92 91.71 46.33 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.9 Cg_endo -74.58 -27.82 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.517 2.145 . . . . 0.0 113.62 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.3 Cg_endo -75.59 -24.05 12.28 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.515 1.477 . . . . 0.0 111.785 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 79.5 mtt85 -116.41 0.45 12.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.2 m120 63.76 41.95 6.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.953 . . . . 0.0 109.445 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -134.69 158.71 43.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.54 155.92 46.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CE2' ' OD2' ' A' ' 70' ' ' ASP . 98.2 m-85 -120.53 136.43 54.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.845 . . . . 0.0 109.41 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 58' ' ' PHE . 23.4 t -121.6 125.25 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.595 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 64' ' ' ILE . 28.3 m -109.57 138.5 45.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.327 -0.858 . . . . 0.0 109.291 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 4.4 m-85 -120.03 138.82 53.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.935 . . . . 0.0 109.576 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.23 -24.02 66.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.192 -0.943 . . . . 0.0 109.15 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -120.06 137.18 54.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 72.6 mtm -65.17 -26.28 68.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.203 -0.936 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 70.2 mm-40 -68.31 -25.58 65.2 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.488 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 20.6 m -73.62 -28.31 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.419 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.869 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.1 -36.33 40.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -69.7 -36.5 75.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.547 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -70.89 -41.61 71.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.574 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 93' ' ' LEU . . . -65.99 -45.24 82.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 105' ' ' VAL . 71.1 t -67.24 -25.22 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.496 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.24 -22.73 41.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.918 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 61' ' ' PHE . 97.0 mt-10 -115.33 -55.01 2.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.113 -0.992 . . . . 0.0 109.742 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.774 HD12 ' HB1' ' A' ' 89' ' ' ALA . 68.3 mt -57.68 -28.22 63.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.179 -0.951 . . . . 0.0 109.603 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 90' ' ' VAL . 36.5 t-20 -79.12 122.88 26.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 92.01 31.53 9.13 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 33.8 p -115.74 163.97 15.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -1.158 . . . . 0.0 109.289 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -126.37 151.35 47.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.514 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -105.45 -165.77 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.365 -0.835 . . . . 0.0 109.074 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -47.51 -25.05 0.98 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 108.76 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.25 36.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 0.0 109.392 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 102' ' ' GLN . 53.8 t -141.42 166.1 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.453 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.597 ' N ' HG12 ' A' ' 101' ' ' VAL . 85.3 mt-30 -120.38 127.12 52.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.38 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.96 122.44 32.98 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.225 -0.922 . . . . 0.0 109.702 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 21.3 mttm -108.59 127.96 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.811 HG11 HG22 ' A' ' 90' ' ' VAL . 61.5 t -116.26 142.51 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 26.6 m120 -138.73 -174.41 3.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.33 -0.856 . . . . 0.0 109.339 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.61 HG22 ' H ' ' A' ' 109' ' ' ARG . 64.5 mt -108.52 140.6 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.53 -33.9 70.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.61 ' H ' HG22 ' A' ' 107' ' ' ILE . 64.1 ttt-85 -117.11 144.7 44.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.479 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -124.05 132.06 53.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -61.38 150.62 79.66 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.187 -0.946 . . . . 0.0 109.497 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.94 -18.02 36.39 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.732 2.288 . . . . 0.0 111.763 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 -179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.17 148.36 62.2 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.246 . . . . 0.0 111.763 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -118.74 148.21 43.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.549 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -57.19 -35.11 69.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.25 -164.37 40.19 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.592 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 53.3 t30 -155.0 88.11 1.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 61.5 m -71.13 137.48 48.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.609 HD21 ' CG2' ' A' ' 90' ' ' VAL . 13.8 tp -115.1 157.19 23.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.336 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.508 ' CD2' ' HB2' ' A' ' 106' ' ' ASN . 72.9 t80 -108.07 120.77 43.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG13 HD21 ' A' ' 103' ' ' LEU . 57.8 t -118.39 131.47 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.327 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 74' ' ' ASN . 75.3 t80 -129.42 147.63 51.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.0 109.574 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.5 179.55 41.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 48' ' ' ASP . 94.7 mt-10 -99.78 157.2 16.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -1.161 . . . . 0.0 109.417 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' GLU . 72.4 m-20 44.34 55.64 5.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.448 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 84.6 mtp -79.98 140.79 36.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.874 . . . . 0.0 109.525 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.58 157.3 77.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.189 -0.944 . . . . 0.0 109.397 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 49.5 Cg_endo -70.81 -55.47 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.659 2.239 . . . . 0.0 111.883 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -35.13 64.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.153 -0.967 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 53' ' ' LEU . 27.6 tp -66.99 -44.89 79.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.163 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.7 mt -67.47 -35.21 78.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.236 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 90.9 mtt180 -62.4 -34.0 75.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.406 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.71 -35.35 19.6 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.597 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -79.98 -5.52 55.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -1.096 . . . . 0.0 109.527 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.616 ' CE2' HG11 ' A' ' 78' ' ' VAL . 29.0 m-85 -131.01 -0.91 4.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.563 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -71.79 -55.58 5.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.9 . . . . 0.0 110.029 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.8 Cg_endo -68.35 -23.48 38.22 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.537 2.158 . . . . 0.0 112.056 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.643 ' CE2' HD21 ' A' ' 93' ' ' LEU . 71.0 m-85 -73.45 -26.11 60.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.157 -0.964 . . . . 0.0 109.495 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 165.65 176.05 36.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -86.23 137.83 32.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -1.158 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 58' ' ' PHE . 82.0 mt -100.26 125.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.476 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 23.0 pt -89.1 -25.91 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -155.81 101.87 2.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.589 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.004 HD23 HG23 ' A' ' 78' ' ' VAL . 3.4 tm? -90.35 131.92 35.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.307 -0.87 . . . . 0.0 109.285 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.75 ' N ' HD13 ' A' ' 67' ' ' LEU . 67.9 m -119.72 149.21 42.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.914 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.434 ' HG3' ' CD1' ' A' ' 67' ' ' LEU . 76.1 mtp -137.62 141.97 41.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.862 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 75' ' ' CYS . 1.4 t0 -130.44 98.73 19.97 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 72' ' ' PRO . 47.6 Cg_endo -75.21 -27.52 9.61 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.503 2.136 . . . . 0.0 113.754 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.598 ' CD ' ' CD ' ' A' ' 71' ' ' PRO . 54.7 Cg_endo -74.93 -24.46 12.97 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 121.505 1.47 . . . . 0.0 111.835 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 71.1 mtt85 -116.08 0.57 13.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' O ' ' CD1' ' A' ' 45' ' ' TYR . 62.3 m-20 62.79 38.88 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' O ' ' N ' ' A' ' 70' ' ' ASP . 4.1 m -136.72 158.89 43.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.188 -0.945 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -147.8 150.13 33.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.1 m-85 -120.0 107.95 13.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -0.985 . . . . 0.0 109.723 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.004 HG23 HD23 ' A' ' 67' ' ' LEU . 10.4 p -101.75 135.84 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.445 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.422 ' O ' HG23 ' A' ' 64' ' ' ILE . 57.5 m -107.9 144.83 34.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.491 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 2.5 m-85 -115.44 153.63 30.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.656 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 95.4 mt-10 -68.84 -27.12 65.55 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.232 -0.917 . . . . 0.0 108.953 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -127.78 144.76 51.07 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.222 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 85.7 mtp -66.25 -27.01 67.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -67.89 -23.38 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 28.8 m -72.98 -28.14 62.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 90' ' ' VAL . . . -79.88 -44.02 21.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.14 -36.16 82.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.601 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -70.34 -44.29 68.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -67.44 -32.75 73.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.39 -0.819 . . . . 0.0 109.339 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.886 HG22 HG11 ' A' ' 105' ' ' VAL . 71.2 t -71.57 -28.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.252 -0.905 . . . . 0.0 109.427 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.15 -25.16 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.556 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' OE1' ' CE1' ' A' ' 61' ' ' PHE . 87.0 tt0 -103.76 -52.47 2.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.616 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' O ' HG23 ' A' ' 96' ' ' THR . 29.3 mt -60.14 -30.58 69.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.681 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 23.6 t-20 -72.13 132.28 43.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.9 43.51 8.85 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 93' ' ' LEU . 27.0 p -121.92 162.62 20.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.252 -1.146 . . . . 0.0 109.427 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.509 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.1 tt0 -134.72 165.55 25.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -122.64 -165.88 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.281 -0.887 . . . . 0.0 109.236 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' A' ' 100' ' ' SER . 72.2 mm-40 -50.25 -22.61 1.83 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.171 -0.955 . . . . 0.0 108.993 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 99' ' ' GLU . 34.8 p 179.9 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.505 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.614 HG12 ' N ' ' A' ' 102' ' ' GLN . 71.9 t -138.55 166.32 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 0.0 109.33 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.614 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.6 mt-30 -127.08 130.17 49.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.491 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.897 HD21 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -97.27 155.18 16.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.521 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 37.6 mttm -136.74 140.96 42.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.171 -0.955 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.886 HG11 HG22 ' A' ' 90' ' ' VAL . 60.2 t -120.14 136.88 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.236 -0.915 . . . . 0.0 109.69 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.508 ' HB2' ' CD2' ' A' ' 43' ' ' TYR . 23.3 m120 -137.3 171.79 13.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 109.275 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 109' ' ' ARG . 56.2 mt -108.4 133.35 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 109.527 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.28 80.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.384 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' H ' HG22 ' A' ' 107' ' ' ILE . 60.4 ttt180 -100.3 140.71 34.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.48 -36.45 84.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.533 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.07 114.06 2.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.251 -0.906 . . . . 0.0 109.461 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.21 146.1 56.46 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.724 2.282 . . . . 0.0 111.834 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.385 -179.89 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.297 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 48.2 Cg_endo -69.38 -14.38 37.18 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.686 2.257 . . . . 0.0 111.742 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -58.75 -33.28 70.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.462 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mttt -60.37 -40.26 90.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.531 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -92.14 -158.52 34.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -159.38 91.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -1.155 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.524 ' CG2' ' HB3' ' A' ' 77' ' ' PHE . 59.5 m -86.86 139.49 30.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.3 -0.875 . . . . 0.0 109.602 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' HB1' ' A' ' 86' ' ' ALA . 5.0 mp -110.88 133.55 53.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 65.9 t80 -88.45 109.83 20.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.915 . . . . 0.0 109.495 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.965 HG13 HD21 ' A' ' 103' ' ' LEU . 68.0 t -104.39 131.73 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 72.0 t80 -117.72 144.81 44.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.474 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 172.66 175.36 40.55 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -117.95 159.99 22.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -1.177 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 45.51 56.01 6.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.353 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.443 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 63.4 mtm -113.9 143.15 45.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.954 ' O ' HD12 ' A' ' 54' ' ' LEU . 2.1 p -119.23 164.8 19.44 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.342 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.6 Cg_endo -68.86 -53.74 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.604 2.202 . . . . 0.0 111.791 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -38.9 70.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.366 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 tp -65.76 -47.52 74.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.262 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.954 HD12 ' O ' ' A' ' 50' ' ' THR . 1.8 mt -62.7 -43.2 99.41 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.307 -0.871 . . . . 0.0 109.301 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.7 ttt180 -54.13 -37.05 63.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.117 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.06 -28.42 62.4 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.535 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.04 -13.51 59.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 109.276 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.75 ' CD2' HG11 ' A' ' 78' ' ' VAL . 49.4 m-85 -127.22 -1.65 6.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 0.0 109.384 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -70.0 -54.8 9.28 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 110.051 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 59' ' ' SER . 44.5 Cg_endo -67.12 -22.82 46.71 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.469 2.113 . . . . 0.0 112.147 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 53.5 m-85 -73.92 -15.22 61.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.193 -0.942 . . . . 0.0 109.473 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 155.76 177.52 29.06 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -87.99 138.13 31.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.436 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.871 HG23 ' O ' ' A' ' 79' ' ' THR . 77.4 mt -102.26 129.8 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG12 HG22 ' A' ' 79' ' ' THR . 26.8 pt -91.36 -19.06 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.454 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' THR . 59.9 t0 -155.9 118.62 4.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.503 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD12 HD13 ' A' ' 64' ' ' ILE . 1.3 tt -117.85 127.76 54.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 109.297 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -121.5 152.92 38.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.539 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.516 ' SD ' HD13 ' A' ' 54' ' ' LEU . 98.4 mmm -123.92 141.96 51.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.351 -0.843 . . . . 0.0 109.39 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -128.43 88.52 52.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.287 -0.883 . . . . 0.0 109.508 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.8 Cg_endo -74.69 -27.7 10.41 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 122.518 2.146 . . . . 0.0 113.63 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.0 Cg_endo -75.59 -23.9 12.42 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.5 1.467 . . . . 0.0 111.813 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 30.7 mtp85 -108.32 -1.47 20.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.736 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 17.8 m120 64.05 41.99 6.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 32.0 p -147.23 160.74 42.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.893 . . . . 0.0 109.408 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -136.04 159.88 40.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.524 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 86.9 m-85 -120.56 136.89 54.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.444 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.882 ' O ' HD12 ' A' ' 42' ' ' LEU . 34.0 t -121.18 128.96 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.959 . . . . 0.0 109.417 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.871 ' O ' HG23 ' A' ' 64' ' ' ILE . 51.0 m -106.34 130.01 54.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.444 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HB2' ' A' ' 61' ' ' PHE . 2.2 m-85 -117.83 133.84 55.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.937 . . . . 0.0 109.597 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -61.38 -34.37 75.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.388 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.48 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 66.4 mtm -71.46 -19.99 62.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.279 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.5 -22.96 58.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.404 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.3 m -75.7 -33.26 60.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.448 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.996 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.67 -43.0 49.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.29 -0.881 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -63.06 -36.48 83.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.526 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -71.3 -35.76 71.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -79.93 -35.11 38.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.371 -0.831 . . . . 0.0 109.401 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.68 ' CG2' HD23 ' A' ' 42' ' ' LEU . 69.9 t -70.44 -31.05 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.507 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.97 -38.76 31.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.146 -0.971 . . . . 0.0 109.697 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 77.7 mm-40 -81.19 -51.63 8.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' CZ ' ' A' ' 58' ' ' PHE . 25.5 mt -62.61 -32.5 73.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.765 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 20.2 t-20 -65.27 127.89 33.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.35 32.57 27.93 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.458 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 69.3 p -121.86 164.64 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -1.15 . . . . 0.0 109.434 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -128.84 162.74 26.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.303 -0.873 . . . . 0.0 109.486 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -103.81 -160.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.301 -0.874 . . . . 0.0 108.989 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -47.64 -25.72 1.27 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 98' ' ' VAL . 0.4 OUTLIER 178.62 36.62 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.502 -0.749 . . . . 0.0 109.48 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.519 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.8 t -138.52 158.0 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 94.9 mt-30 -102.89 127.85 49.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.0 109.237 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.965 HD21 HG13 ' A' ' 44' ' ' VAL . 1.7 tt -102.72 157.37 17.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 109.62 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 84.0 mttt -135.78 134.82 39.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.664 ' CG1' HG13 ' A' ' 90' ' ' VAL . 9.1 p -113.84 139.65 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.707 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 82.5 m-20 -137.25 171.27 14.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.46 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 54.1 mt -116.31 130.64 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.62 142.9 51.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.243 -0.911 . . . . 0.0 109.295 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -145.67 169.22 18.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.923 . . . . 0.0 109.568 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -56.26 -33.77 65.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.92 . . . . 0.0 109.459 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.73 80.5 24.27 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 0.0 109.406 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.84 -16.34 41.35 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.703 2.269 . . . . 0.0 111.821 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.9 mtm . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.458 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.39 -22.43 33.78 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -58.32 -34.6 70.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 0.0 109.479 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -60.97 -28.91 69.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.518 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.52 -172.23 42.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.806 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 23.6 t-20 -157.93 90.97 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -1.178 . . . . 0.0 109.478 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 91.3 m -76.7 133.85 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.028 HD21 ' HB1' ' A' ' 86' ' ' ALA . 57.8 mt -114.46 145.92 41.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -0.921 . . . . 0.0 109.528 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 68.5 t80 -99.69 115.4 29.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.475 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 105' ' ' VAL . 47.7 t -109.14 136.65 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.474 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 70.1 t80 -123.66 144.75 49.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.5 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 49' ' ' MET . . . 171.78 167.78 32.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ASP . 23.1 pt-20 -98.5 151.98 20.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -1.132 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.7 m-20 45.03 64.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.428 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.404 ' HE2' ' O ' ' A' ' 46' ' ' GLY . 57.6 mtm -111.81 139.61 47.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.318 -0.864 . . . . 0.0 109.466 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.53 ' O ' HD12 ' A' ' 54' ' ' LEU . 31.0 p -119.62 159.9 44.29 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 48.8 Cg_endo -69.44 -36.63 11.28 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.687 2.258 . . . . 0.0 111.798 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 p -69.94 -44.31 69.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.469 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.6 tp -61.27 -38.08 85.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.401 -0.812 . . . . 0.0 109.384 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 50' ' ' THR . 8.2 mt -66.89 -40.4 87.76 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.309 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.507 ' O ' ' CB ' ' A' ' 59' ' ' SER . 70.0 mtt180 -60.22 -32.76 71.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.371 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.58 -36.41 43.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.42 -17.87 50.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.327 -1.102 . . . . 0.0 109.323 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CE2' HD12 ' A' ' 93' ' ' LEU . 49.4 m-85 -115.14 -2.25 12.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.454 -0.778 . . . . 0.0 109.435 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 2.0 t -62.87 -54.22 48.94 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.3 Cg_endo -67.93 -23.31 41.05 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.583 2.189 . . . . 0.0 112.443 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.75 ' HE2' HD21 ' A' ' 93' ' ' LEU . 43.5 m-85 -72.53 -20.25 61.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.0 109.607 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 160.67 -177.36 37.11 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -95.5 127.5 41.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -1.108 . . . . 0.0 109.451 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.761 HG23 ' O ' ' A' ' 79' ' ' THR . 57.8 mt -96.38 127.24 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.582 ' CG2' ' CG ' ' A' ' 81' ' ' GLU . 22.0 pt -100.14 -15.59 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' HB3' ' CB ' ' A' ' 79' ' ' THR . 60.2 t0 -142.13 115.76 9.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.282 -0.887 . . . . 0.0 109.457 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.477 HD22 ' HE ' ' A' ' 55' ' ' ARG . 19.6 tp -121.31 117.08 26.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.356 -0.84 . . . . 0.0 109.33 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 77' ' ' PHE . 39.0 m -113.63 153.55 28.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.616 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.446 ' CG ' ' HB3' ' A' ' 51' ' ' PRO . 94.0 mmm -125.22 141.0 52.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -0.868 . . . . 0.0 109.389 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' CB ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER -125.96 91.26 48.57 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.463 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.605 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 46.2 Cg_endo -74.58 -28.1 10.27 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.489 2.126 . . . . 0.0 113.627 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.51 -24.34 12.13 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.532 1.488 . . . . 0.0 111.739 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 27.6 ttm180 -111.11 -2.22 15.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 78.6 m-20 63.47 42.54 6.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.962 . . . . 0.0 109.55 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.502 ' SG ' ' CB ' ' A' ' 70' ' ' ASP . 30.8 p -140.36 165.02 28.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.77 156.02 46.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.479 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 98.9 m-85 -118.16 139.58 51.06 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 45.7 t -126.01 124.47 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.875 . . . . 0.0 109.584 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 64' ' ' ILE . 91.4 m -103.36 137.56 41.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 0.0 109.295 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' OH ' ' HB3' ' A' ' 58' ' ' PHE . 2.1 m-85 -120.15 151.57 38.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.955 . . . . 0.0 109.541 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' CG ' ' CG2' ' A' ' 65' ' ' ILE . 91.8 mt-10 -78.02 -29.29 49.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -113.25 136.59 52.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.777 . . . . 0.0 109.33 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' A' ' 40' ' ' ASN . 95.8 mmm -60.81 -31.1 70.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -70.76 -27.7 64.13 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 0.0 109.628 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 41.3 m -64.37 -35.9 82.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.236 -0.915 . . . . 0.0 109.548 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.028 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -75.89 -45.41 35.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -62.78 -35.13 78.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -66.85 -46.54 74.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.919 . . . . 0.0 109.585 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -63.58 -44.53 93.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.829 HG22 ' CG1' ' A' ' 105' ' ' VAL . 99.6 t -68.28 -25.51 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.221 -0.924 . . . . 0.0 109.437 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.11 -20.13 45.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.484 ' O ' ' CG2' ' A' ' 96' ' ' THR . 94.6 mt-10 -116.97 -53.96 2.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.75 HD21 ' HE2' ' A' ' 61' ' ' PHE . 35.1 mt -59.41 -34.81 72.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 31.1 t30 -67.9 126.03 28.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.494 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.77 40.89 7.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 21.7 p -130.24 163.88 25.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -1.159 . . . . 0.0 109.439 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.453 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 62.6 tt0 -123.97 163.49 21.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.472 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -118.05 -162.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 108.951 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -51.46 -22.16 2.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.976 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 177.9 35.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.388 -0.82 . . . . 0.0 109.329 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 102' ' ' GLN . 56.1 t -140.88 165.72 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.269 -0.894 . . . . 0.0 109.559 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.605 ' N ' HG12 ' A' ' 101' ' ' VAL . 89.8 mt-30 -117.89 124.35 48.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.298 -0.876 . . . . 0.0 109.246 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 103' ' ' LEU . 17.8 mt -97.35 123.45 41.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.257 -0.902 . . . . 0.0 109.673 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 48.5 tttp -119.65 119.61 34.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.928 . . . . 0.0 109.325 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.829 ' CG1' HG22 ' A' ' 90' ' ' VAL . 35.2 t -111.01 149.79 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.731 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 87.4 m-20 -139.32 175.99 9.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -0.862 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.4 mt -118.12 128.69 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 0.0 109.582 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.84 149.75 29.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.417 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 34.5 mtm-85 -120.26 141.52 49.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.261 -0.899 . . . . 0.0 109.527 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -126.67 146.14 50.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 0.0 109.363 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.38 160.62 49.61 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.126 -0.984 . . . . 0.0 109.514 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.65 145.64 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.743 2.295 . . . . 0.0 111.829 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.15 143.45 53.8 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 122.769 2.313 . . . . 0.0 111.786 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HD2' ' CE ' ' A' ' 110' ' ' LYS . 14.6 mtt-85 -126.75 141.92 51.69 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -56.39 -33.58 65.89 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.946 . . . . 0.0 109.424 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' TYR . . . -47.88 -42.72 22.63 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.549 ' OD1' ' HB2' ' A' ' 86' ' ' ALA . 29.3 t-20 52.05 71.54 0.45 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.335 -1.097 . . . . 0.0 109.347 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 55.5 m -72.8 136.92 45.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.186 -0.946 . . . . 0.0 109.488 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.924 HD13 ' HB1' ' A' ' 86' ' ' ALA . 16.0 tp -107.31 157.5 17.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.24 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.444 ' HH ' ' HB3' ' A' ' 75' ' ' CYS . 60.1 t80 -105.15 132.21 51.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.523 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 103' ' ' LEU . 57.2 t -128.27 125.56 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.456 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 104' ' ' LYS . 64.4 t80 -114.46 135.41 54.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA3' ' SD ' ' A' ' 49' ' ' MET . . . 178.46 158.13 20.48 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.7 155.6 17.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.274 -1.133 . . . . 0.0 109.558 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 45.99 57.8 4.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.4 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.434 ' SD ' ' HA3' ' A' ' 46' ' ' GLY . 61.4 mtm -104.67 141.27 36.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.574 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 4.1 p -121.11 163.09 32.01 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.291 -0.88 . . . . 0.0 109.367 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' N ' ' SD ' ' A' ' 69' ' ' MET . 49.5 Cg_endo -70.03 -28.43 23.97 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 122.649 2.233 . . . . 0.0 111.756 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.6 p -74.01 -44.38 54.69 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.405 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.5 tp -62.15 -41.42 98.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.23 -41.01 86.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.225 -0.922 . . . . 0.0 109.313 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 21.4 ttt85 -53.71 -40.27 65.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.61 -34.91 38.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -80.07 -6.6 57.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.355 -1.085 . . . . 0.0 109.465 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.72 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 42.2 m-85 -130.67 -1.54 4.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 109.649 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.567 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -70.08 -55.71 8.03 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.178 -0.951 . . . . 0.0 110.006 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 59' ' ' SER . 45.2 Cg_endo -67.55 -25.13 41.26 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.587 2.192 . . . . 0.0 111.934 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.659 ' CE2' HD21 ' A' ' 93' ' ' LEU . 65.5 m-85 -72.49 -18.91 61.63 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.163 -0.961 . . . . 0.0 109.265 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 156.03 -177.46 33.08 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -92.9 134.66 34.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -1.153 . . . . 0.0 109.408 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.598 HG21 ' HB2' ' A' ' 67' ' ' LEU . 56.9 mt -96.38 118.49 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.526 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.514 ' CG2' ' HG2' ' A' ' 81' ' ' GLU . 24.8 pt -86.43 -24.49 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.368 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.46 95.4 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' HB2' HG21 ' A' ' 64' ' ' ILE . 2.1 tt -91.9 130.3 37.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.332 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.551 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 70.5 m -121.33 156.1 33.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.708 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.464 ' SD ' ' N ' ' A' ' 51' ' ' PRO . 70.9 mtp -145.12 140.61 28.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.317 -0.864 . . . . 0.0 109.427 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' CYS . 6.5 m-20 -129.22 101.81 19.13 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 47.5 Cg_endo -75.03 -27.67 9.77 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.512 2.141 . . . . 0.0 113.664 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.2 Cg_endo -75.21 -25.85 11.15 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 121.461 1.44 . . . . 0.0 111.727 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.455 ' O ' ' SG ' ' A' ' 75' ' ' CYS . 84.8 mtt180 -112.87 -1.06 14.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.3 -0.875 . . . . 0.0 109.672 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 58.2 m-20 63.15 41.82 7.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.166 -0.959 . . . . 0.0 109.56 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.514 ' O ' ' N ' ' A' ' 70' ' ' ASP . 3.8 m -141.73 158.11 44.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 68' ' ' SER . . . -146.3 153.28 40.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 82.5 m-85 -122.95 110.79 15.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.9 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.524 HG11 ' CE2' ' A' ' 58' ' ' PHE . 9.0 p -101.34 136.72 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.433 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 47.2 m -103.54 127.99 50.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.071 -1.018 . . . . 0.0 109.659 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 1.5 m-85 -107.14 143.73 34.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.394 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.514 ' HG2' ' CG2' ' A' ' 65' ' ' ILE . 93.2 mt-10 -66.77 -32.24 73.4 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -117.51 139.81 50.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HG2' ' HB2' ' A' ' 40' ' ' ASN . 89.2 mtp -62.5 -32.12 72.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.533 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' A' ' 84' ' ' GLU . 72.5 mm-40 -64.04 -26.59 68.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.449 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 80' ' ' TYR . 19.3 m -67.77 -33.35 74.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.925 . . . . 0.0 109.537 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.924 ' HB1' HD13 ' A' ' 42' ' ' LEU . . . -75.4 -41.23 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -68.11 -38.68 82.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.923 . . . . 0.0 109.489 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -64.88 -38.49 91.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.755 ' HB1' ' CD1' ' A' ' 93' ' ' LEU . . . -72.94 -35.54 67.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.301 -0.874 . . . . 0.0 109.317 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 86' ' ' ALA . 90.5 t -64.48 -28.89 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.553 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.26 -38.01 31.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 109.7 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.58 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 97.0 mt-10 -92.17 -49.66 6.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.221 -0.924 . . . . 0.0 109.889 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.993 ' HB2' HG21 ' A' ' 105' ' ' VAL . 38.9 mt -60.47 -36.84 79.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.201 -0.937 . . . . 0.0 109.676 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 50.9 t30 -72.2 126.05 28.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.413 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.55 45.14 5.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 92' ' ' GLU . 37.4 p -129.89 162.2 29.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -1.149 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.402 ' HG2' ' N ' ' A' ' 98' ' ' VAL . 63.7 tt0 -130.38 157.63 42.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.928 . . . . 0.0 109.523 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -110.24 -165.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.286 -0.884 . . . . 0.0 109.068 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -48.16 -24.9 1.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.127 -0.983 . . . . 0.0 108.764 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -179.15 34.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.386 -0.821 . . . . 0.0 109.424 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 102' ' ' GLN . 64.9 t -138.81 166.47 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.444 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.601 ' N ' HG12 ' A' ' 101' ' ' VAL . 92.7 mt-30 -118.67 135.44 54.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.546 HD21 HG13 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -110.13 156.42 20.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.202 -0.936 . . . . 0.0 109.523 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 45' ' ' TYR . 16.9 mttp -140.31 134.69 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 0.0 109.308 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.993 HG21 ' HB2' ' A' ' 93' ' ' LEU . 27.8 t -113.45 139.56 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 105' ' ' VAL . 81.1 m-20 -137.21 172.81 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.281 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 60.4 mt -111.81 128.15 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -109.96 144.53 38.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.379 -0.826 . . . . 0.0 109.35 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.1 ttt180 -126.34 145.3 50.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.559 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.454 ' CE ' ' HD2' ' A' ' 37' ' ' ARG . 64.3 mttm -87.16 133.6 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.865 . . . . 0.0 109.363 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.43 79.52 70.64 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.954 . . . . 0.0 109.638 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.09 145.39 55.11 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.712 2.275 . . . . 0.0 111.71 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.438 -179.926 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.6 Cg_endo -69.67 147.96 64.57 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.719 2.279 . . . . 0.0 111.742 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -121.67 155.73 34.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.178 -0.951 . . . . 0.0 109.489 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -94.28 148.96 21.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 -170.17 37.76 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.662 ' ND2' ' HB3' ' A' ' 86' ' ' ALA . 48.2 t-20 -152.87 88.4 1.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -1.142 . . . . 0.0 109.468 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 82.3 m -74.2 132.68 42.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.515 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD21 ' HB1' ' A' ' 86' ' ' ALA . 61.4 mt -114.9 144.69 43.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 109.292 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 106' ' ' ASN . 73.8 t80 -84.97 128.98 34.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 103' ' ' LEU . 58.5 t -122.78 136.23 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB3' ' HB3' ' A' ' 104' ' ' LYS . 75.6 t80 -132.33 138.9 47.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.13 167.97 38.98 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.678 ' OE2' HG22 ' A' ' 101' ' ' VAL . 24.5 pt-20 -96.76 147.2 24.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -1.072 . . . . 0.0 109.475 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 47' ' ' GLU . 79.0 m-20 43.08 62.66 1.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.408 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.4 mtm -102.66 141.95 34.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.849 . . . . 0.0 109.732 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.54 ' O ' HD12 ' A' ' 54' ' ' LEU . 16.8 p -122.0 162.36 37.62 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.115 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 50' ' ' THR . 47.9 Cg_endo -68.94 -52.12 0.41 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 122.681 2.254 . . . . 0.0 111.81 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -39.32 71.87 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.157 -0.964 . . . . 0.0 109.48 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.3 tp -64.6 -45.62 86.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.372 -0.83 . . . . 0.0 109.17 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 50' ' ' THR . 6.1 mt -65.23 -47.95 75.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.181 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 59' ' ' SER . 62.3 ttt-85 -49.34 -36.73 22.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.116 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.55 -32.85 57.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' HD11 ' A' ' 93' ' ' LEU . . . -80.05 -12.3 59.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.357 -1.084 . . . . 0.0 109.376 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.636 ' CE2' HD12 ' A' ' 93' ' ' LEU . 76.0 m-85 -124.73 -2.19 7.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.353 -0.842 . . . . 0.0 109.469 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -70.64 -52.73 10.4 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 110.301 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 59' ' ' SER . 46.1 Cg_endo -68.35 -27.75 33.81 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.34 2.026 . . . . 0.0 112.272 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 48.9 m-85 -72.52 -18.05 61.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.979 -1.076 . . . . 0.0 109.447 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.3 -176.41 38.68 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -98.79 131.61 44.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.187 -1.184 . . . . 0.0 109.472 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.856 HG23 ' O ' ' A' ' 79' ' ' THR . 50.7 mt -94.86 127.88 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -0.921 . . . . 0.0 109.693 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 66' ' ' ASP . 27.3 pt -81.37 -28.74 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 0.0 109.299 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 67' ' ' LEU . 60.4 t0 -147.96 148.04 30.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -0.88 . . . . 0.0 109.339 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 11.6 tp -130.81 120.77 24.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 t -121.44 159.59 25.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -0.917 . . . . 0.0 109.686 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 86.2 mtp -137.42 147.7 45.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.33 -0.856 . . . . 0.0 109.334 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' C ' ' HD2' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -120.41 100.42 47.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.195 -0.941 . . . . 0.0 109.515 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.603 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 45.8 Cg_endo -74.85 -27.94 9.88 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.461 2.107 . . . . 0.0 113.483 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 71' ' ' PRO . 55.6 Cg_endo -75.86 -25.65 10.35 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.53 1.487 . . . . 0.0 111.773 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 78.7 mtt180 -111.26 -0.45 16.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 109.753 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 73.4 m-20 62.52 40.32 10.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 43' ' ' TYR . 27.7 p -139.81 157.93 44.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.522 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.92 167.57 15.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -127.23 129.77 48.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.342 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 58' ' ' PHE . 21.3 t -117.58 123.85 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 64' ' ' ILE . 37.2 m -101.07 137.04 39.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.845 . . . . 0.0 109.116 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' OH ' ' CA ' ' A' ' 58' ' ' PHE . 1.6 m-85 -116.76 138.56 51.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.129 -0.982 . . . . 0.0 109.721 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -65.56 -24.91 67.21 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.353 -0.842 . . . . 0.0 109.291 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -120.58 140.09 52.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.225 -0.922 . . . . 0.0 109.296 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.7 mtt -67.25 -26.09 66.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.35 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 70.3 mm-40 -71.88 -24.04 61.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -0.915 . . . . 0.0 109.536 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -73.27 -28.51 62.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.966 . . . . 0.0 109.408 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' HB1' HD21 ' A' ' 42' ' ' LEU . . . -79.79 -44.6 20.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.486 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.56 -35.93 82.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 109.632 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -75.19 -33.79 61.46 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.503 ' HA ' ' CD1' ' A' ' 61' ' ' PHE . . . -77.07 -41.53 41.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.317 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.7 HG22 HG11 ' A' ' 105' ' ' VAL . 75.7 t -66.98 -29.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.404 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -75.08 -38.28 61.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.323 -0.861 . . . . 0.0 109.544 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 61' ' ' PHE . 75.2 mm-40 -88.51 -44.33 10.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.15 -0.969 . . . . 0.0 109.638 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 96' ' ' THR . 18.5 mt -65.04 -42.75 94.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.585 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 90' ' ' VAL . 55.0 t-20 -59.08 128.32 36.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.214 -0.929 . . . . 0.0 109.578 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.44 51.19 5.03 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 93' ' ' LEU . 71.7 p -131.68 165.9 22.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -1.171 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -135.95 160.44 38.6 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.533 ' CG2' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -112.43 -162.52 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 0.0 109.067 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -54.82 -20.46 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 108.855 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.68 36.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.45 -0.781 . . . . 0.0 109.357 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.678 HG22 ' OE2' ' A' ' 47' ' ' GLU . 41.3 t -142.71 166.4 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.152 -0.967 . . . . 0.0 109.483 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.588 ' N ' HG12 ' A' ' 101' ' ' VAL . 90.8 mt-30 -127.41 134.35 49.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.687 HD21 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -106.27 160.12 15.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 45' ' ' TYR . 22.2 tptp -140.61 121.69 14.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.237 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.7 HG11 HG22 ' A' ' 90' ' ' VAL . 21.6 t -109.2 133.56 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 43' ' ' TYR . 28.2 m120 -127.22 169.49 13.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 109.294 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' ARG . 53.7 mt -106.32 133.38 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.143 -0.973 . . . . 0.0 109.551 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.33 -34.62 76.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' ILE . 12.3 mtt85 -53.14 151.53 4.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.323 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' GLN . 68.8 mttt 57.42 47.87 15.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.399 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 112' ' ' PRO . 0.0 OUTLIER -43.69 -58.82 4.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.249 -0.907 . . . . 0.0 109.381 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 111' ' ' GLN . 49.9 Cg_endo -70.49 -11.03 29.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.622 2.215 . . . . 0.0 111.632 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.7 mtp . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.482 -179.969 . . . . . . . . 0 0 . 1 stop_ save_